KR100852737B1 - Composition prepared from lythrum salicaia having antioxidant and liver protecting activities - Google Patents

Composition prepared from lythrum salicaia having antioxidant and liver protecting activities Download PDF

Info

Publication number
KR100852737B1
KR100852737B1 KR1020070047221A KR20070047221A KR100852737B1 KR 100852737 B1 KR100852737 B1 KR 100852737B1 KR 1020070047221 A KR1020070047221 A KR 1020070047221A KR 20070047221 A KR20070047221 A KR 20070047221A KR 100852737 B1 KR100852737 B1 KR 100852737B1
Authority
KR
South Korea
Prior art keywords
extract
fraction
activity
liver
antioxidant
Prior art date
Application number
KR1020070047221A
Other languages
Korean (ko)
Inventor
이승은
성낙술
방진기
김금숙
박충범
차선우
정해영
장인복
Original Assignee
대한민국
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 대한민국 filed Critical 대한민국
Priority to KR1020070047221A priority Critical patent/KR100852737B1/en
Priority to CN2008101611100A priority patent/CN101347471B/en
Application granted granted Critical
Publication of KR100852737B1 publication Critical patent/KR100852737B1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00Function of food ingredients
    • A23V2200/30Foods, ingredients or supplements having a functional effect on health
    • A23V2200/302Foods, ingredients or supplements having a functional effect on health having a modulating effect on age
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/333Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

An extract of Lythrum salicaria roots and a fraction thereof are provided to show excellent antioxidizing activity and hepatic fibrosis inhibitory effect, thereby being applied as a medicine and a health functional food having antioxidant and liver protecting activities. A pharmaceutical composition for preventing or treating liver cirrhosis comprises 0.001-99.999 wt.% of an extract of Lythrum salicaria roots as an effective ingredient, wherein the extract is obtained by using a solvent such as water, methanol, ethanol, and a mixture thereof. Further, the extract comprises a fraction and a weight ratio of the extract and the fraction is 99.999:0.001 to 50:50.

Description

털부처꽃 추출물을 포함하는 항산화 및 간 보호 활성을 갖는 조성물{COMPOSITION PREPARED FROM LYTHRUM SALICAIA HAVING ANTIOXIDANT AND LIVER PROTECTING ACTIVITIES}COMPOSITION PREPARED FROM LYTHRUM SALICAIA HAVING ANTIOXIDANT AND LIVER PROTECTING ACTIVITIES}

도 1은 털부처꽃 뿌리의 메탄올 추출물로부터 조제된 용매별 분획물의 흰쥐혈액 중 TNF-α 생성에 대한 감소 효과를 나타낸 그래프이다.FIG. 1 is a graph showing a reduction effect on TNF-α production in rat blood of solvent-specific fractions prepared from methanol extract of hairy roots.

도 2는 털부처꽃 뿌리의 메탄올 추출물로부터 조제된 용매별 분획물의 흰쥐 간장 중 GST 활성 완화 효과를 나타낸 그래프이다.FIG. 2 is a graph showing the effect of alleviating the GST activity in the rat liver of the solvent-specific fractions prepared from the methanol extract of the hairy roots.

도 3은 털부처꽃 뿌리의 50% 에탄올 추출물(LSR, 40, 200, 1000 ppm 처리)의 YPEN1 세포에서 t-BHT로 유도된 활성산소(ROS) 생성 저해 효과를 나타낸 그래프이다.Figure 3 is a graph showing the inhibitory effect of t-BHT-induced reactive oxygen (ROS) production in YPEN1 cells of 50% ethanol extract (LSR, 40, 200, 1000 ppm treatment) of hairy roots.

도 4는 털부처꽃 뿌리의 50% 에탄올 추출물(LSR, 1, 10, 50, 100, 1000 ppm 처리)의 BV2 세포에서 LPS로 유도된 NO 생성 저해 활성을 나타낸 그래프이다.Figure 4 is a graph showing the LPS-induced NO production inhibitory activity in BV2 cells of 50% ethanol extract (LSR, 1, 10, 50, 100, 1000 ppm treatment) of hairy roots.

도 5는 털부처꽃 뿌리의 50% 에탄올 추출물(LSR, 1, 10, 50, 100, 1000 ppm 처리)의 동물 신경세포(SH-SY5Y) 생존율에 대한 효과를 나타낸 그래프이다.Figure 5 is a graph showing the effect on the survival rate of animal neurons (SH-SY5Y) of 50% ethanol extract (LSR, 1, 10, 50, 100, 1000 ppm treatment) of hairy roots.

도 6은 털부처꽃 뿌리의 50% 에탄올 추출물(LSR, 0.125, 0.25, 0.5 g/㎏ 투여)의, 사염화탄소로 간섬유화가 유도된 흰쥐 간장 중 지질과산화물질(TBARS) 생성 감소 효과를 나타낸 그래프이다.FIG. 6 is a graph showing the effect of 50% ethanol extract (LSR, 0.125, 0.25, 0.5 g / kg administration) of hairy buds roots on the reduction of lipid peroxide (TBARS) production in liver liver induced by carbon tetrachloride.

도 7은 털부처꽃 뿌리의 50% 에탄올 추출물(LSR, 0.125, 0.25, 0.5 g/㎏ 투여)의, 사염화탄소로 간섬유화가 유도된 흰쥐 간장 중 항산화물질 함량 유지 효과를 나타낸 그래프이다.Figure 7 is a graph showing the effect of maintaining the antioxidant content in liver liver fibrillation induced by carbon tetrachloride of 50% ethanol extract (LSR, 0.125, 0.25, 0.5 g / kg administration) of hairy roots.

도 8은 털부처꽃 뿌리의 50% 에탄올 추출물(LSR, 0.125, 0.25, 0.5 g/㎏ 투여)의, 사염화탄소로 간섬유화가 유도된 흰쥐 간장 중의 무독화효소(GST) 활성 완화 효과를 나타낸 그래프이다.8 is a graph showing the effect of detoxifying enzyme (GST) activity in rat liver induced with hepatic fibrosis with carbon tetrachloride of 50% ethanol extract (LSR, 0.125, 0.25, 0.5 g / kg administration) of hairy roots.

도 9는 털부처꽃 뿌리의 50% 에탄올 추출물(LSR, 0.125, 0.25, 0.5 g/㎏ 투여)의, 사염화탄소로 간섬유화가 유도된 흰쥐 간장 중 콜라겐 함량 감소 효과를 나타낸 그래프이다.Figure 9 is a graph showing the effect of reducing collagen content in rat liver induced fibrosis with carbon tetrachloride of 50% ethanol extract (LSR, 0.125, 0.25, 0.5 g / kg administration) of hairy roots.

도 10은 면역조직화학분석에 의한 털부처꽃 뿌리의 50% 에탄올 추출물(LSR, 0.125, 0.25, 0.5 g/㎏ 투여)의 흰쥐 간장 섬유화지표물질(콜라겐) 감소 효과를 보여주는 배율 ×100의 현미경사진이다. FIG. 10 is a micrograph of magnification × 100 showing the effect of reducing 50% ethanol extract (LSR, 0.125, 0.25, 0.5 g / kg) of rat hepatic fibrosis marker (collagen) by immunohistochemical analysis. .

도 11은 조직학적 분석에 의한 털부처꽃 뿌리의 50% 에탄올 추출물(LSR, 0.125, 0.25, 0.5 g/㎏ 투여)의 흰쥐 간장 섬유화 감소 효과를 보여주는 배율 ×100의 현미경사진이다.FIG. 11 is a micrograph of magnification × 100 showing the effect of reducing 50% ethanol extract (LSR, 0.125, 0.25, 0.5 g / kg) of rat hepatic fibrosis in hairy roots by histological analysis.

본 발명은 털부처꽃 추출물을 포함하는 항산화 및 간 보호 활성을 갖는 조성물에 관한 것으로, 구체적으로는 털부처꽃 뿌리로부터 얻은 추출물 및 용매별 분획 물의 항산화 활성 및 간 보호 활성 용도에 관한 것이다.The present invention relates to a composition having an antioxidant and hepatoprotective activity, including a hairy hyacinth extract, and more particularly, to the use of the antioxidant activity and hepatoprotective activity of extracts obtained from the hairy hyacinth root and fractions for each solvent.

현대인들은 서구화된 식생활과 스트레스, 흡연, 유해물질로 인해 여러 가지 성인병에 노출되어 있으며, 최근에는 여기에 가중하여 알코올의 과다섭취에 의한 건강문제도 대두 되고 있다. 우리나라에서 알코올성 간질환은 전체 간질환의 14.5%를 차지하고, 더욱이 68.8%로 가장 큰 비중을 차지하는 B형 간염의 39.8%도 알코올성 간질환과 합병증을 나타내는 것으로 알려져 있다(이창홍. 대한소화기학회 세미나, 2002). 통계청 자료에서도 우리나라에서 간질환에 의한 사망률 중 알코올성 간질환으로 의한 사망률이 차지하는 비율이 해마다 급증하고 있어(1990년도의 2.7%에서 2004년의 33.0%로), 이에 대한 예방대책이 필요하다.Modern people are exposed to various adult diseases due to westernized diet, stress, smoking, and harmful substances, and recently, health problems caused by excessive intake of alcohol are also increasing. In Korea, alcoholic liver disease accounts for 14.5% of all liver diseases, and 39.8% of hepatitis B, which occupies the largest proportion of 68.8%, is also known to show alcoholic liver disease and complications (Lee Chang-hong. ). According to the statistics of the National Statistical Office, the proportion of mortality caused by alcoholic liver disease among the mortality caused by liver disease in Korea is increasing rapidly from year to year (from 2.7% in 1990 to 33.0% in 2004), and preventive measures are necessary.

일반적으로 생체는 에너지를 생성하는 데 산소를 이용하지만, 그 중 일부는 산화적 스트레스의 주원인인 유해한 활성산소로 변화되기도 한다. 산화적 스트레스는 환경으로부터 생체로 유입된 약물, 흡연, 자외선 조사 등의 요인에 의해서도 야기될 수 있으며 알코올도 이러한 약물 중의 하나이다. 활성산소가 산화적 스트레스의 주된 물질이 되는 이유는, 산소분자의 전자껍질에서 짝을 이루지 못한 불안정한 전자, 즉 라디칼의 형태로 존재하기 때문으로, 수퍼옥사이드 음이온(superoxide anion, O2 -·), 히드록실 라디칼(hydroxyl radical, OH·), 1중항 산소(singlet oxygen, 1O2) 등이 그 예이다(Evans, C.R. et al., Free radicals and oxidative stress: environment, drugs and food additives. Portland Press. 1-31. 1995). 활성산소를 위시한 이들 산화적 스트레스는 생체막 구성 지방산의 산화, DNA나 단백질과 같은 생체 고분자의 산화 및 교차결합에 의한 돌연변이를 유발하며, 결국 암을 비롯한 여러 질병의 발병과 노화에 직결된다(Frei B. Natural antioxidants in human health and disease. Academic Press. 25-55. 1994).In general, living organisms use oxygen to generate energy, but some of them are converted to harmful free radicals, which are the main cause of oxidative stress. Oxidative stress can also be caused by factors such as drugs that enter the living body from the environment, smoking, ultraviolet irradiation, etc. Alcohol is one such drug. The reason the free radicals that are the main material of the oxidative stress, as due to the form of not paired in the electron shell unstable electron, that is a radical of molecular oxygen, superoxide anion (superoxide anion, O 2 - · ), Examples are hydroxyl radicals (OH ·), singlet oxygen ( 1 O 2 ), and others (Evans, CR et. al ., Free radicals and oxidative stress: environment, drugs and food additives. Portland Press. 1-31. 1995). These oxidative stresses, including free radicals, cause mutations due to oxidation of biofilm-forming fatty acids, oxidation and cross-linking of biopolymers such as DNA and proteins, and are thus directly linked to the onset and aging of many diseases including cancer (Frei B). Natural antioxidants in human health and disease.Academic Press. 25-55. 1994).

산화적 스트레스는 대개 생체 고유의 항산화 메카니즘에 의해 어느 정도는 제거되지만, 생체의 대응능력을 초과하는 경우에는 이를 보완할 수 있는 항산화제의 공급이 필요하다. 즉, 생체에 유입된 라디칼을 제거하거나 생체 항산화물질의 고갈을 막을 수 있고, 항산화효소의 활성에 영향을 주는 항산화물질이 이러한 산화적 스트레스를 막을 수 있다.Oxidative stress is usually eliminated to some extent by the inherent antioxidant mechanisms, but in the case of exceeding the body's ability to respond, it is necessary to supply antioxidants to compensate for this. In other words, it is possible to remove radicals introduced into the living body or to prevent the depletion of biological antioxidants, and antioxidants that affect the activity of antioxidant enzymes may prevent such oxidative stress.

한편, 알코올이 산화적 스트레스가 되는 이유는 그 자체가 유해 라디칼로 분해되기 때문이다. 즉, 알코올 분해 대사 과정에서 MEOS(microsomal ethanol oxidation system)에 의해 수퍼옥사이드 음이온, α-히드록시에틸 라디칼, 퍼페릴 이온(perferryl ion, Fe3 +O2 -·), 제1철-2산소-제2철 복합체(ferrous dioxygen ferric complex, Fe2 +O2 -Fe3 +) 등의 활성산소종이 생성되어 환원형 글루타치온, 비타민 A, 비타민 C, 비타민 E, 카로티노이드, 단백질-티올(protein-thiol)의 감소를 야기하고, 과산화물질인 말론디알데하이드(MDA, malondialdehyde), 비헴철, CYPⅡE1, 카보닐 프로테인(carbonyl protein)의 수준을 증가시킨다. 따라서, 만성적인 알코올 섭취에 의한 산화적 스트레스가 적절히 제거되지 않으면 단기적으로는 숙취, 장기적으로는 간질환의 원인이 될 수 있다.On the other hand, the reason why alcohol becomes oxidative stress is because it decomposes itself into harmful radicals. That is, the alcoholysis superoxide anion by (microsomal ethanol oxidation system) MEOS in metabolic processes, α- hydroxyethyl radical, a perylene buffer ion (perferryl ion, Fe 3 + O 2 - ·), a ferrous oxygen -2- Active oxygen species such as ferrous dioxygen ferric complex (Fe 2 + O 2 - Fe 3 + ) are produced to reduce glutathione, vitamin A, vitamin C, vitamin E, carotenoids and protein-thiol And increase the levels of the peroxides malondialdehyde (MDA, malondialdehyde), non-heme iron, CYPIIE1, carbonyl protein. Therefore, if the oxidative stress caused by chronic alcohol intake is not properly eliminated, it may cause a hangover in the short term and liver disease in the long term.

털부처꽃(이우철, 한국식물명고, 1996)은 또 다른 이름으로 좀부처꽃(정태현 등 3인, 조선식물명집, 1949), 참부처꽃(박만규, 우리나라식물명감, 1949) 및 털두렁꽃(김현삼 등 4인, 식물원색도감 과학백과사전, 1988)이라고도 하며, 구황본초(救荒本草, 중국 명나라 주숙, 1406)에서는 털부처꽃과 부처꽃의 전초를 천굴채(千屈菜)라고도 칭하였다. 털부처꽃의 영명은 Purple Loosestrife, Spiked Loosestrife로 불리며, 학명은 정명으로 Lythrum salicaria L.을 사용(Sp. pl. 446, 1753) 하지만 L. argyi , L. intermedium , L. propinquum , L. quadrifolium , L. salicaria subsp . intermedium , L. salicaria var . glabricaule , L. salicaria var. glabrum , L. salicaria var . intermedium , L. salicaria var . mairei , L. salicaria var . tomentosum , L. salicaria var . vulgare , L. salicaria var . vulgare subvar . glabricaule , L. tomentosum 등 다양한 이명을 사용하는 것으로 알려져 있으며, Salicaria spicata Lam.(Fl. Fr.3:103, 1778) 혹은 Salicaria vulgris Moench(Method. 664, 1794) 등의 이명으로도 불린다.Hairy Buddha (Lee Woo-cheol, Korea Botanical Garden, 1996) is another name for Joombu Buddha (Three persons including Jeong Tae-hyun, Joseon Botanical Garden, 1949), True Buddha (Park Man-gyu, Korean Plant Perspective, 1949), and Tumulus (Kim Hyunsam). Phosphorus, Botanical Primitive Color Book, Encyclopedia of Science, 1988). In the case of Guhwangboncho (救 荒 本草, Ming Dynasty, China), the outposts of hairy buddha and buddha were also called Cheongulchae. The name of the hair bud is called Purple Loosestrife, Spiked Loosestrife, and the scientific name is Lythrum. salicaria L. (Sp. Pl . 446, 1753), but L. argyi , L. intermedium , L. propinquum , L. quadrifolium , L. salicaria subsp . intermedium , L. salicaria var . glabricaule , L. salicaria var. glabrum , L. salicaria var . intermedium , L. salicaria var . mairei , L. salicaria var . tomentosum , L. salicaria var . vulgare , L. salicaria var . vulgare subvar . It is known to use various tinnitus such as glabricaule , L. tomentosum , and Salicaria spicata Lam. (Fl. Fr. 3: 103, 1778) or Salicaria vulgris Moench (Method. 664, 1794).

향약생약대사전(정보섭 등 2인, 영림사, 1990)에는 털부처꽃의 전초와 뿌리가 약리작용을 가지며, 특히 청혈, 지혈, 양혈의 효능과 이질, 궤양, 세균성 이질에 효과가 있으며, 전초에는 살리카린(salicarin)과 탄닌이 함유되어 있고 꽃에는 비텍신(vitexin), 오리엔틴(orientin), 말빈(malvin), 시아니딘-3-모노갈락토사이드(cyanidin-3-monogalactoside), 몰식자산, 엘라직산(ellagic acid), 클로로게닉산(chlorogenic acid) 등이 함유되어 있다고 기재되어 있다.In the herbal medicine medicinal dictionaries (Jung-sup Lee, Younglimsa, 1990), the outposts and roots of hairy buds have pharmacological effects, and are particularly effective in blue blood, hemostasis, and blood transfusions, dysentery, ulcers, and bacterial dysentery. It contains salicarin and tannins, and the flowers contain vitexin, orientin, malvin, cyanidin-3-monogalactoside, gluttony, elazic acid (ellagic acid), chlorogenic acid and the like are described.

전문학술지에 실린 털부처꽃의 효능에 대한 연구 보고를 살펴보면, 국내 연 구 보고는 확인되지 않았으며 외국학술잡지에서 털부처꽃 잎에서 조제된 추출물의 DPPH 및 리놀레산에 대한 항산화 실험결과와 실험동물에서의 항염증 및 항통증 효과[Tunalier et al., J. Ethnopharmacology(in press), 2006]가 보고되었고, 과혈당 마우스에서의 효과(Lamela et al., J. Ethnopharmacology 15(2):153-160, 1986) 및 정상 혈당 흰쥐에 대한 효과(Lamela et al., J. Ethnopharmacology 14(1):83-91, 1985), 항미생물 효과(Becker et al., Fitoterapia 7(6):580-584, 2005), 항미생물 화합물(Rauha et al., International J. Food Microbiol. 56(1):3-12, 2000) 및 항리스테리아균 활성(Nurten et al., Pharmaceutical Biol. 44(2):91-94, 2006)에 대해 보고되어 있다.In the research reports on the efficacy of hairy buds in professional journals, domestic research reports were not confirmed, and the results of antioxidant experiments on DPPH and linoleic acid of extracts prepared from hairy buds leaves in foreign journals and anti-animal activity in experimental animals Inflammatory and anti-pain effects [Tunalier et al ., J. Ethnopharmacology (in press), 2006] and reported effects on hyperglycemic mice (Lamela et. al ., J. Ethnopharmacology 15 (2): 153-160, 1986) and effects on normal blood glucose rats (Lamela et al. al ., J. Ethnopharmacology 14 (1): 83-91, 1985), antimicrobial effects (Becker et al ., Fitoterapia 7 (6): 580-584, 2005), antimicrobial compounds (Rauha et al ., International J. Food Microbiol. 56 (1): 3-12, 2000) and antibacterial activity (Nurten et. al ., Pharmaceutical Biol. 44 (2): 91-94, 2006).

한편, 털부처꽃을 재료로 한 특허출원을 검색하면 충치 및 치주질환에 유효한 구강용 조성물(출원번호 1019960010675, 등록), 구강용 마이크로캡슐의 제조방법 및 이 방법에 의해 제조된 마이크로캡슐을 함유하는 구강용 조성물(출원번호 1020020013758, 등록), 식물추출물 파우더의 제조방법 및 이 방법에 의해 제조되는 식물추출물 파우더를 함유하는 구강용 조성물(출원번호 1019990043040, 등록) 및 꽃 원료를 함유하는 제과류의 제조방법(출원번호 1020057019041, 공개) 등에 관한 것이 있으며, 유사종인 부처꽃을 소재로 한 기능성 관련하여 항산화조성물과 외용조성물에서 세포부형제로 언급(출원번호 1020057013882, 공개)되어 있다.On the other hand, if you search for a patent application made of hair-blowing flowers, oral composition (application No. 1019960010675, registered) effective for dental caries and periodontal disease, a method for preparing oral microcapsules, and an oral cavity containing microcapsules prepared by the method Composition (application number 1020020013758, registered), method for producing plant extract powder and composition for oral cavity containing plant extract powder (application number 1019990043040, registered) produced by the method and method for producing confectionery containing floral raw materials ( Application No. 1020057019041, published), and is referred to as a cell excipient (anti-application 1020057013882, published) in the antioxidant composition and the external composition in relation to the functionality based on the similar species of Buddha flower.

이와 같이 국내외 학술논문과 국내 특허출원 내용을 살펴보았을 때, 털부처꽃 뿌리 추출물의 항산화 활성이나 간장 보호 활성을 다룬 논문이나 특허는 알려져 있지 않은 것으로 확인된다.Thus, when looking at domestic and international academic papers and domestic patent applications, it is confirmed that there are no known papers or patents dealing with the antioxidant activity and the hepatic protective activity of hairy root extract.

이에, 본 발명자들은 우리나라 자생 식물자원을 대상으로 항산화 활성을 탐색하던 중 선발된 털부처꽃의 뿌리를 재료로 하여 in vitro에서 유리기 소거능 및 세포 생존율에 의한 독성검사 및 사염화탄소를 투여한 흰 쥐에서의 in vivo 항산화 활성 및 간장 보호 효능을 검정하였다. 그 결과, 털부처꽃 뿌리의 추출물 및 용매별 분획물이 항산화 및 간 보호 활성을 보유한 사실을 확인하여 본 발명의 완성에 이르게 되었다.Accordingly, the present inventors made the root of the hair bud flower selected during the search for antioxidant activity in the native plant resources of Korea in Toxicity test by free radical scavenging ability and cell viability in vitro and in rats treated with carbon tetrachloride in vivo Antioxidant activity and hepatoprotective efficacy were assayed. As a result, it was confirmed that the extract and the solvent-specific fractions of hairy roots of the roots have antioxidant and hepatoprotective activity, which led to the completion of the present invention.

본 발명의 목적은 항산화 및 간 보호 활성을 갖는 식물 기원의 조성물을 제공하고자 하는 것이다.It is an object of the present invention to provide a composition of plant origin with antioxidant and hepatoprotective activity.

상기 목적을 달성하기 위하여 본 발명은 털부처꽃(Lythrum salicaria) 뿌리의 추출물을 유효성분으로 포함하는 항산화 및 간 보호 활성을 갖는 조성물을 제공한다.In order to achieve the above object, the present invention provides a composition having antioxidant and hepatoprotective activity comprising an extract of the root of Lythrum salicaria as an active ingredient.

여기에서, 상기 추출물에는 분획물이 포함되고, 추출물과 분획물의 배합비율은 중량비로 99.999:0.001 내지 50:50인 것이 바람직하다. 분획물은 유기용매 분획물로서, 특히 헥산, 에텔, 에틸아세테이트 및 부탄올 분획물이 바람직하다.Here, the extract includes a fraction, and the blending ratio of the extract and the fraction is preferably 99.999: 0.001 to 50:50 by weight. The fraction is an organic solvent fraction, in particular the hexane, ether, ethyl acetate and butanol fractions.

또한, 상기 추출물은 조성물 전체에 대하여 0.001∼99.999 중량%인 것이 바람직하다. In addition, the extract is preferably 0.001 to 99.999% by weight based on the total composition.

그리고, 상기 추출물은 메탄올이나 에탄올과 같은 저급알코올 또는 물과 저급알코올의 혼합용매로 추출하여 얻을 수 있다.The extract may be obtained by extracting a lower alcohol such as methanol or ethanol or a mixed solvent of water and lower alcohol.

이하, 본 발명을 더욱 구체적으로 설명한다.Hereinafter, the present invention will be described in more detail.

본 발명에 따른 털부처꽃 뿌리의 추출물은 건조된 털부처꽃 뿌리 중량의 약 10∼20 배 부피의 용매를 사용하여 냉장 온도 내지 100 ℃, 바람직하게는 70 내지 90 ℃의 온도에서 약 2 시간 내지 24 시간 환류 추출, 진탕추출 또는 초음파 추출 등의 방법에 의해 2 회 내지 5 회 반복 추출하고, 추출액을 감압 농축하여 얻을 수 있다. 50% 에탄올추출물의 경우, 수득율은 약 15%이다.The extract of the hair bud root according to the present invention is about 2 hours to 24 hours at a temperature of refrigeration temperature to 100 ℃, preferably 70 to 90 ℃ using a solvent of about 10 to 20 times the volume of the dried hair bud root Extraction may be repeated two to five times by a method such as reflux extraction, shaking extraction, or ultrasonic extraction, and the extract may be obtained by concentrating under reduced pressure. For 50% ethanol extract, the yield is about 15%.

여기에서, 추출 용매는 메탄올, 에탄올 등의 저급 알코올 또는 물과 저급 알코올의 99.999:0.001 내지 0.001:99.999의 혼합비를 갖는 혼합용매를 사용할 수 있다.Here, the extraction solvent may be a lower alcohol such as methanol, ethanol or a mixed solvent having a mixing ratio of 99.999: 0.001 to 0.001: 99.999 of water and lower alcohol.

본 발명에 따른 털부처꽃 추출물은 GLP 연구기관(한국화학연구원 부설 안전성 평가 연구소)에 의뢰 수행된 랫드 단회투여시험에서 안전한 것으로 확인되었으며 향약생약대사전(정보섭 등 2인, 영림사, 1990)에서는 구황식물로의 사용 및 신장, 위장 순환기계에서의 무독성이 언급되어 있어 인체에 대한 안전성이 어느 정도 인정된다.Hair bud extract according to the present invention was confirmed to be safe in a single dose test of rats commissioned by GLP research institute (Korea Institute of Chemical Research Safety Evaluation Institute). The use of furnaces and the non-toxicity of the kidneys and the gastrointestinal circulatory system are mentioned, and some safety to humans is recognized.

또한, 본 발명 조성물의 간 보호 활성에는 알코올에서 비롯된 지방간, 간염, 간경화 등의 간질환으로부터의 보호 활성을 포함한다.In addition, the hepatoprotective activity of the composition of the present invention includes a protective activity against liver diseases such as fatty liver, hepatitis, cirrhosis and the like derived from alcohol.

본 발명에 따른 털부처꽃 뿌리의 추출물을 유효성분으로 하는 조성물은 성인의 경우 1일 0.1 ~ 2g/㎏의 양을 1∼3 회에 나누어 경구 투여 또는 비 경구 투여할 수 있다.The composition comprising the extract of the hairy root of the root according to the present invention as an active ingredient may be administered orally or orally by dividing the amount of 0.1 to 2 g / kg 1 to 3 times per day for adults.

또한, 본 발명에 따른 털부처꽃 뿌리의 추출물을 유효성분으로 하는 조성물 은 통상의 주사제, 산제, 과립제, 캅셀제, 정제, 액제 등으로 또는 크림제, 연고제, 로션 등 피부 외용제로 제형화 될 수 있다.In addition, the composition using the extract of the hairy root of the root according to the present invention as an active ingredient may be formulated into conventional injections, powders, granules, capsules, tablets, liquids and the like or external skin preparations such as creams, ointments, lotions.

이하, 실시예를 통하여 본 발명을 더욱 상세히 설명한다. 단, 이들 실시예는 본 발명의 예시일 뿐, 본 발명의 범위가 이들만으로 한정되는 것은 아니다.Hereinafter, the present invention will be described in more detail with reference to Examples. However, these Examples are only illustrative of the present invention, and the scope of the present invention is not limited to these.

실시예Example 1: One: 털부처꽃Hair bud 뿌리의 메탄올 추출물 및 용매별  Methanol Extracts of Roots and Their Solvents 분획물의Fraction 제조 Produce

털부처꽃 뿌리는 2005년 수원 농촌진흥청 작물과학원 약용작물 시험포장에서 종자증식을 통해 수확한 것을 세척한 후 동결 건조하고 건조 시료를 가루로 만들어 추출물 조제에 사용하였다.Hairy roots were harvested from seed growth at the Suwon Rural Development Administration's Medicinal Crop Experimental Packaging in 2005, freeze-dried and dried to make powder extracts.

시료 중량의 10 배에 해당하는 메탄올을 가하여 74 ℃에서 2 시간씩 2 회 반복 추출하였다. 추출액을 감압 농축하고 남은 메탄올 및 수분을 동결 건조하여 제거한 후 in vitro 항산화실험에 사용하였다. 이 과정을 통해 얻어진 메탄올추출물의 수율은 9.54%였다.Methanol corresponding to 10 times the weight of the sample was added and extracted twice at 74 ° C. for 2 hours. The extract was concentrated under reduced pressure, and the remaining methanol and water were freeze-dried and removed in It was used for in vitro antioxidant experiment. The yield of methanol extract obtained through this process was 9.54%.

얻어진 메탄올 추출물의 일부는 증류수로 용해한 후 헥산, 에텔, 에틸아세테이트 및 부탄올로 순차적으로 분획한 후 감압 농축 및 동결 건조하여 각각의 용매별 분획물을 얻어 화학반응계에서의 활성실험 및 동물실험에 사용하였다. 특히, 헥산 분획물-1은 분획과정에서 헥산에 완전히 용해되는 부분을 취한 것이고, 헥산 분획물-2는 헥산으로 분획시 물층과 헥산층의 중간에 존재하는 부분만을 취한 것이다.A part of the obtained methanol extract was dissolved in distilled water, and then sequentially partitioned into hexane, ether, ethyl acetate and butanol, concentrated under reduced pressure and freeze-dried to obtain fractions for each solvent, and used in activity experiments and animal experiments in chemical reaction systems. Particularly, hexane fraction-1 is a part which is completely dissolved in hexane during the fractionation process, and hexane fraction-2 is only a part that is present between the water layer and the hexane layer when fractionated with hexane.

실시예Example 2: 세포 실험 및 동물활성 검정을 위한  2: for cell experiments and animal activity assays 털부처꽃Hair bud 뿌리 추출물의 제조 Preparation of Root Extract

실시예 1과 동일한 털부처꽃 뿌리를 대상으로 in vitro 세포 실험과 동물실 험을 수행하기 위한 50% 에탄올 추출물은 추출물을 제조하였다.In the same hairy roots as Example 1 in 50% ethanol extract was prepared for performing in vitro cell and animal experiments.

시료 중량의 10배 부피에 해당하는 50% 에탄올을 가하여 85 ℃에서 2 시간씩 2 회 반복 추출하였다. 추출액을 감압 농축하여 용매를 제거하고 동결 건조하여 수분을 제거하였다. 이때 수율은 약 15.07%였다. 50% ethanol corresponding to 10 times the volume of the sample weight was added thereto, and extracted twice at 85 ° C. for 2 hours. The extract was concentrated under reduced pressure to remove the solvent and freeze dried to remove moisture. The yield was about 15.07%.

실험예Experimental Example 1: 메탄올 추출물 및 용매별  1: Methanol Extract and Solvent Specific 분획물의Fraction 화학반응계에서의In a chemical reaction system 항산화활성 검정 Antioxidant activity assay

1. DPPH(1,1-diphenyl-2-picrylhydrazyl) 라디칼 소거능 실험1. DPPH (1,1-diphenyl-2-picrylhydrazyl) radical scavenging activity

Blois의 방법(Antioxidant determinations by the use of a stable free radical. Nature 181:1199-1200, 1958)에 따라, 에탄올성 1.5×10-4 M의 DPPH 반응액 2.97 ㎖을 여러 농도의 시료 0.03 ㎖와 혼합하고 3 분 후에 517 ㎚에서 흡광도를 측정하였다. 추출물의 DPPH에 대한 소거능은 RC50, 즉 용매만을 사용한 대조군의 흡광도를 50% 감소시키는 데 필요한 농도로 나타내거나, 일정 농도에서 대조군의 흡광도에 대한 소거능(%)으로 나타내었고, 소거효과의 비교를 위한 대조물질로 α-토코페롤을 사용하였다.According to Blois' method (Antioxidant determinations by the use of a stable free radical.Nature 181: 1199-1200, 1958), 2.97 ml of an ethanol 1.5 × 10 -4 M DPPH reaction solution was mixed with 0.03 ml of various concentration samples. After 3 minutes the absorbance at 517 nm was measured. The scavenging ability of the extract to DPPH was expressed as RC 50 , the concentration required to reduce the absorbance of the control using only solvent by 50%, or as the scavenging activity (%) of the absorbance of the control at a certain concentration. Α-tocopherol was used as a control.

2. 저밀도 지단백(low density lipoprotein, LDL) 산화에 대한 저해활성2. Inhibitory Activity against Low Density Lipoprotein (LDL) Oxidation

Miller et al .의 방법(In vitro antioxidant effects of estrogens with a hindered 3-OH function on the copper-induced oxidation of low density lipoprotein. Steroids 61:305-308, 1996)을 변형하여, 50∼100 ㎍의 단백질을 함유하도록 조제한 인간 LDL을 일정 농도의 추출물 0.02 ㎖, 10 mM 인산 완충 생리식 염수(PBS; phosphate-buffered saline) 0.115 ㎖ 및 0.25 mM CuSO4 0.04 ㎖와 함께 37 ℃에서 3 시간 동안 반응시켰다. 이 반응액에 20% TCA 1 ㎖를 가해 반응을 중단시킨 후, 0.05 N NaOH에 녹인 0.67% TBA 1 ㎖를 가하고 95 ℃에서 15 분간 가열, 냉각을 순차적으로 행하고 3,000 rpm에서 15 분간 원심분리한 후 분리된 상등액 중에 함유된 말론디알데히드(MDA)의 양을 540 ㎚에서 측정하여 대조군에 대한 저해율(%)로서 결과를 나타내었다.Miller et al . Method of In in vitro antioxidant effects of estrogens with a hindered 3-OH function on the copper-induced oxidation of low density lipoprotein. Steroids 61: 305-308, 1996), human LDL formulated to contain 50-100 μg of protein, 0.02 ml of a constant concentration, 0.115 ml of 10 mM phosphate-buffered saline (PBS). And 0.04 ml of 0.25 mM CuSO 4 at 37 ° C. for 3 hours. 1 ml of 20% TCA was added to the reaction solution to stop the reaction. Then, 1 ml of 0.67% TBA dissolved in 0.05 N NaOH was added thereto, followed by heating and cooling at 95 ° C. for 15 minutes, followed by centrifugation at 3,000 rpm for 15 minutes. The amount of malondialdehyde (MDA) contained in the separated supernatant was measured at 540 nm and the results were expressed as% inhibition to the control.

3. 총 페놀 함량 분석3. Total Phenolic Content Analysis

항산화활성에 영향을 미치는 페놀화합물의 양을 비교하기 위해, Kim et al .의 방법(Effect of solvents and some extraction conditions on antioxidant activity in cinnamon extracts. Korean J. Food Sci. Technol. 25:204-209, 1993)에 준하여 실시하였다. 일정 농도의 털부처꽃 추출물 0.1 ㎖와 2% Na2CO3 2 ㎖을 혼합하고, 2 분 후 50% Folin-Ciocalteau 시약 0.1 ㎖를 첨가하였다. 상온에서 30 분간 방치한 후 750 ㎚에서 측정된 흡광도를 가지고 탄닌산을 표준물질로 사용한 검량선식(r=0.9973)에 대입하여 총 페놀 함량을 산출하였다.To compare the amount of phenolic compounds that affect antioxidant activity, Kim et al. al . (Effect of solvents and some extraction conditions on antioxidant activity in cinnamon extracts. Korean J. Food Sci. Technol. 25: 204-209, 1993). 0.1 ml of a certain amount of hairy lotus extract and 2 ml of 2% Na 2 CO 3 were mixed, and after 2 minutes, 0.1 ml of 50% Folin-Ciocalteau reagent was added. After leaving at room temperature for 30 minutes, the total phenol content was calculated by substituting the calibration curve (r = 0.9973) using tannic acid as a standard with absorbance measured at 750 nm.

4. 분석 결과4. Analysis result

털부처꽃 뿌리의 메탄올 추출물 및 이로부터 분리된 용매별 분획물의 화학반응계에서의 항산화활성의 결과는 다음 표 1에 나타낸 바와 같다.The results of the antioxidant activity in the chemical reaction system of the methanol extract of the hairy roots and the solvent-specific fractions separated therefrom are shown in Table 1 below.

털부처꽃 뿌리의 메탄올 추출물 및 분획물의 화학반응계에서의 항산화활성 및 총페놀 함량 Antioxidant Activity and Total Phenolic Content in the Chemical Reaction System of Methanol Extracts and Fractions of Hairy Root Flower 분석항목 시료Analysis item sample DPPH 소거능 (SC50 , ㎍/㎖)DPPH scavenging activity (SC 50 , μg / ml) LDL 산화저해능 (IC50 , ㎍/㎖)LDL oxidation inhibition (IC 50 , μg / ml) 총 페놀 함량* (%)Total Phenolic Content * (%) 메탄올추출물Methanol extract 7.507.50 -- 20.5±0.3020.5 ± 0.30 헥산 분획물-1Hexane Fraction-1 29.6229.62 6.866.86 11.85±0.0711.85 ± 0.07 헥산 분획물-2Hexane Fraction-2 7.607.60 4.654.65 24.52±0.7824.52 ± 0.78 에텔 분획물Ether fractions 6.216.21 4.154.15 48.17±0.1848.17 ± 0.18 에틸아세테이트 분획물Ethyl acetate fraction 4.904.90 4.534.53 46.50±0.0846.50 ± 0.08 부탄올 분획물Butanol fraction 5.225.22 2.652.65 44.92±0.2844.92 ± 0.28 물 분획물Water fraction 5.385.38 3.553.55 22.94±0.8922.94 ± 0.89

* 탄닌산 당량* Tannic acid equivalent

① 메탄올 추출물의 경우 DPPH 라디칼에 대한 소거능(SC50)은 7.50 ㎍/㎖로서, α-토코페롤의 13.52 ㎍/㎖ (Lee et al ., 한국약용작물학회지 13(3):171-176, 2002)보다 우수하였다.① In the case of methanol extract, the scavenging ability (SC 50 ) for DPPH radical is 7.50 μg / mL, which is 13.52 μg / mL of α-tocopherol (Lee et al . , 13 (3): 171-176, 2002).

② 항산화활성과 상관성이 높은 총 페놀 함량을 분석한 결과, 털부처꽃 뿌리의 메탄올 추출물의 총페놀 함량은 20.5%로 나타났다.② As a result of analyzing total phenolic content which has a high correlation with antioxidant activity, total phenolic content of methanol extract of hairy root was 20.5%.

③ 털부처꽃 뿌리의 용매별 분획물 중에서 헥산 분획물-1을 제외한 모든 분획에서 DPPH 라디칼에 대한 우수한 소거능을 나타내었으며, 에틸아세테이트 분획물, 부탄올 분획물, 물 분획물, 에텔 분획물 및 헥산 분획물-2의 순으로 그 효과가 우수하였다 (SC50, 4.90∼7.60 ㎍/㎖).③ All fractions except hexane fraction-1 among the solvent fractions of hairy roots showed excellent scavenging ability against DPPH radicals, followed by ethyl acetate fraction, butanol fraction, water fraction, ether fraction and hexane fraction-2. Was excellent (SC 50 , 4.90-7.60 μg / ml).

④ 분획물의 LDL의 산화에 대한 저해능(IC50)도 2.65∼6.86 ㎍/㎖로서, 털부처꽃 뿌리의 모든 용매별 분획물이 매우 효과적인 활성을 나타내었다.④ The inhibitory activity (IC 50 ) on the oxidation of LDL of fractions was also 2.65∼6.86 ㎍ / ml, and all solvent fractions of hairy roots showed very effective activity.

⑤ 또한, 분획물 100 g에 대한 총페놀 함량(%)은 에텔 분획물, 에틸아세테이트 분획물 및 부탄올 분획물이 각각 48.2%, 46.5% 및 44.9%로서 비교적 높은 함량을 나타내었으며, 헥산 분획물-1과 헥산 분획물-2 및 물 분획물은 11.9∼24.52 %로서 비교적 낮은 함량을 보였다. 따라서, 항산화활성은 에텔 분획, 에틸아세테이트 분획과 부탄올 분획에서 우수할 것으로 예상된다.⑤ In addition, the total phenolic content (%) for 100 g of fractions was relatively high in the ethylene fraction, ethyl acetate fraction and butanol fraction as 48.2%, 46.5% and 44.9%, respectively, hexane fraction-1 and hexane fraction- 2 and water fractions showed a relatively low content of 11.9 to 24.52%. Therefore, the antioxidant activity is expected to be excellent in the ether fraction, ethyl acetate fraction and butanol fraction.

실험예Experimental Example 2: 2: 용매별 By solvent 분획물의Fraction 흰쥐에서의In rats 간장보호 활성 검정 Hepatoprotective Activity Assay

1. 동물실험 계획1. Animal experiment plan

실험동물로는 체중 200 g 전후의 Sprague Dawley계 수컷 흰쥐를 사용하였고, 각 분획물 및 양성대조물질(Silymarin, 실리마린) 투여량은 100∼300 ㎎/체중 ㎏/래트/일(1 회/일, 총 4일)로 하였으며, 독성유발은 체중 ㎏ 당 CCl4 1 ㎖을 옥수수유 2 ㎖에 녹여 복강주사 하였다. 사료는 시판 고형사료(샘타코)를 사용하고, 실험군은 다음 표 2와 같이 구성하였으며, 흰쥐는 각 실험군 당 8 마리씩 무작위로 배정하였다. 헥산 분획물-1과 헥산 분획물-2는 분쇄한 후 혼합하여 실험에 사용하였다.Sprague Dawley male rats weighing about 200 g were used as experimental animals, and the fractions and positive control (Silymarin, Silymarin) doses were 100-300 mg / kg body weight / rat / day (1 time / day, total). Toxicity was induced by intraperitoneal injection of 1 ml of CCl 4 per kg body weight in 2 ml of corn oil. For the feed, a commercial solid feed (Sam taco) was used, and the experimental group was configured as shown in Table 2, and rats were randomly assigned to 8 animals in each experimental group. Hexane fraction-1 and hexane fraction-2 were pulverized and mixed to use in the experiment.

정상군 (Normal)Normal 음성대조군(NC)Negative Control (NC) 양성대조군(PC)Positive control group 용매분획물 투여군Solvent fraction administration group 경구 투여 물질Oral administration 담체carrier 담체carrier 실리마린+담체Silymarin + carrier 헥산 분획물 (Hfr.) +담체Hexane Fraction (Hfr.) + Carrier 에텔 분획물 (Efr.) +담체Ethyl Fraction (Efr.) + Carrier 에틸아세테이트 분획물 (EAfr.) +담체Ethyl acetate fraction (EAfr.) + Carrier 부탄올 분획물 (Bfr.) +담체Butanol fraction (Bfr.) + Carrier 물 분획물 (Wfr.) +담체Water Fraction (Wfr.) + Carrier CCl4 주사CCl 4 injections 무처리 No treatment 처리process 처리process 처리process 처리process 처리process 처리process 처리process

실험동물은 일 주일간 예비사육으로 실험실에 적응시킨 후 실험을 실시하였으며, 실험실은 22±2 ℃로 일정한 온도를 유지하였다. 활성분석을 위해 동물을 희생시키기 24 시간 전에는 사료공급을 중단하고 물만 공급하였으며, 에텔로 마취한 후 개복하여 복부대정맥에서 채혈하고 0.9% 식염수로 관류한 후 간장을 적출하였다.The experimental animals were adapted to the laboratory by preliminary breeding for one week, and the experiment was conducted. The laboratory maintained a constant temperature at 22 ± 2 ° C. Twenty four hours before the sacrifice of animals for activity analysis, feeding was stopped and only water was supplied. After anesthesia with an ether, the stomach was opened, blood was collected from the abdominal vein, perfused with 0.9% saline, and the liver was extracted.

2. 혈청분리 및 간장으로부터의 효소액 조제2. Serum Separation and Preparation of Enzyme Solution from Soy Sauce

채혈된 혈액은 30 분 이상 냉장고에서 정치시킨 후 3,000 rpm에서 10분간 원심분리한 다음 혈청을 분리하여 TNF-α(tumor necrosis factor-α)의 분석에 사용하였다. GST(glutathione-S-transferase)의 활성분석을 위해 적출된 간장은 그 중량의 4 배 부피의 0.1 M 인산나트륨 완충액(pH 7.4)으로 테플론 균질화기(teflon homogenizer)에서 균질화시킨 후, 10,000 g에서 20 분간 원심분리하여 얻어진 상등액을 105,000 g에서 1 시간 동안 초원심분리하여 다시 얻어진 상등액(cytosol 분획)을 분리하였다.The collected blood was left in the refrigerator for at least 30 minutes, centrifuged at 3,000 rpm for 10 minutes, and serum was separated and used for analysis of TNF-α (tumor necrosis factor-α). Extracted soy sauce for the analysis of glutathione-S-transferase (GST) activity was homogenized in a teflon homogenizer with 0.1 M sodium phosphate buffer (pH 7.4) in volume four times its weight, and then 20 to 10,000 g. The supernatant (cytosol fraction) obtained by ultracentrifuging the supernatant obtained by centrifugation for 10 minutes at 105,000 g was separated.

3. 혈청 중의 TNF-α 함량 분석3. Analysis of TNF-α Content in Serum

염증 관련 사이토카인의 하나인 TNF-α 생성에 대한 털부처꽃 뿌리의 저해 활성을 보기 위해, 키트(Endogen ER3TNFA5)를 사용하여 분석하였다.To see the inhibitory activity of hairy roots on TNF-α production, one of inflammation-related cytokines, the kit (Endogen ER3TNFA5) was analyzed.

4. 간장 중의 GST 활성 분석4. Analysis of GST Activity in Soy Sauce

적출된 간 cytosol 일정량을 인산칼륨 완충액(pH 6.5) 2800 ㎕, 0.04 M 환원형 글루타치온 75 ㎕와 함께 혼합하여 25 ℃, 5 분간 예비배양한 후 0.12 M 2,4-디니트로클로로벤젠(DNCB) 25 ㎕를 가해 25 ℃, 2 분간 반응시키고, 20% TCA 500 ㎕를 가해 반응을 종결시켰으며, 순차적으로 1,500×g에서 10 분간 원심분리하고 상등액은 340 ㎚에서 흡광도를 측정하였다. 결과는 효소활성(conjugated DNCB nM/㎎ 단백질)=(흡광도/9.6)×(1/효소액 중 ㎎ 단백질)/2 분)의 식에 따라 산출하였다.The extracted liver cytosol was mixed with 2800 μl of potassium phosphate buffer (pH 6.5) and 75 μl of 0.04 M reduced glutathione, preincubated at 25 ° C. for 5 minutes, and then 0.12 M 2,4-dinitrochlorobenzene (DNCB) 25 The reaction was terminated by adding μl to 25 ° C. for 2 minutes and terminating the reaction by adding 500 μl of 20% TCA, sequentially centrifuged at 1,500 × g for 10 minutes, and the supernatant was measured for absorbance at 340 nm. The results were calculated according to the formula of enzyme activity (conjugated DNCB nM / mg protein) = (absorbance / 9.6) × (mg protein in 1 / enzyme solution / 2 minutes).

5. 분석 결과5. Analysis result

(1) 털부처꽃 뿌리의 메탄올 추출물로부터 조제된 용매별 분획물의 흰쥐 혈액 중 TNF-α 생성에 대한 감소 효과(1) Reduction Effect of Solvent Fractions Prepared from Methanol Extract of Hairy Root Flower on TNF-α Production in Rat Blood

도 1은 털부처꽃 뿌리의 메탄올 추출물로부터 조제된 용매별 분획물의 흰쥐혈액 중 TNF-α 생성에 대한 감소 효과를 나타낸 그래프이다. 여기에서 Normal은 사염화탄소 무처리 정상군, NC는 사염화탄소 처리 대조군, Sil은 사염화탄소 및 실리마린(시판 간장약) 투여 대조군, Hfr.는 사염화탄소 및 털부처꽃 뿌리의 헥산 분획물 투여군, Efr.는 사염화탄소 및 털부처꽃 뿌리의 에텔 분획물 투여군, EAfr.는 사염화탄소 및 털부처꽃 뿌리의 에틸아세테이트 분획물 투여군, Bfr.은 사염화탄소 및 털부처꽃 뿌리의 부탄올 분획물 투여군, 그리고 Wfr.는 사염화탄소 및 털부처꽃 뿌리의 물 분획물 투여군을 나타낸다.FIG. 1 is a graph showing a reduction effect on TNF-α production in rat blood of solvent-specific fractions prepared from methanol extract of hairy roots. Where Normal is the carbon tetrachloride-free normal group, NC is the carbon tetrachloride-treated control group, Sil is the carbon tetrachloride and silymarin (commercial soy sauce) control group, Hfr. Etel fraction administration group, EAfr. Is the ethyl acetate fraction administration group of carbon tetrachloride and hairy roots, Bfr. Is the butanol fraction administration group of carbon tetrachloride and hairy roots, and Wfr.

도 1에서 보듯이, 염증성 사이토카인 TNF-α의 흰쥐 혈청 중 함량을 분석한 결과, 음성대조군(NC, 83 pg/㎖)에서 정상군(Normal, 54 pg/㎖)보다 그 함량이 높아진 TNF-α 함량은 에텔 분획물(Efr., 18 pg/㎖) 투여로 음성대조군 대비 78.5% 감소 효과를 나타내 그 효과가 가장 우수하였으며 이는 양성 대조물질인 실리마린 투여군(Sil. 47 pg/㎖)의 44% 감소 효과 보다도 우수한 것이다. 또한, 에텔 분획물 보다는 다소 약하지만 에틸아세테이트 분획물(EAfr., 64 pg/㎖) 과 헥산 분획물(Hfr., 74.2 pg/㎖) 및 부탄올 분획물(Bfr., 75.3 pg/㎖)도 각각 23.1%, 9.5% 및 10.8%로 비교적 감소 효과를 나타내었다.As shown in Figure 1, the result of analyzing the content of the inflammatory cytokine TNF-α in the rat serum, TNF- which is higher than the normal group (Normal, 54 pg / ㎖) in the negative control group (NC, 83 pg / ㎖) α content was decreased 78.5% compared to the negative control group by the administration of the ether fraction (Efr., 18 pg / ㎖), which is the most effective, 44% reduction of the silymarin administration group (Sil. 47 pg / ㎖), a positive control It is superior to the effect. Also slightly weaker than the ether fraction, the ethyl acetate fraction (EAfr., 64 pg / ml), the hexane fraction (Hfr., 74.2 pg / ml) and the butanol fraction (Bfr., 75.3 pg / ml) were 23.1% and 9.5, respectively. % And 10.8% showed a relatively decreasing effect.

(2) 털부처꽃 뿌리의 메탄올 추출물로부터 조제된 용매별 분획물의 흰쥐 간장 중 GST 활성 완화 효과(2) Effect of Solvent Fractions Prepared from Methanol Extract of Hairy Root Flower Root on GST Activity Mitigation in Rat Liver

도 2는 털부처꽃 뿌리의 메탄올 추출물로부터 조제된 용매별 분획물의 흰쥐 간장 중 GST 활성 완화 효과를 나타낸 그래프이다. 여기에서, Normal, NC, PC(=Sil), Hfr., Efr., EAfr., Bfr., 및 Wfr.는 각각 위에서 정의한 바와 같다.FIG. 2 is a graph showing the effect of alleviating the GST activity in the rat liver of the solvent-specific fractions prepared from the methanol extract of the hairy roots. Here, Normal, NC, PC (= Sil), Hfr., Efr., EAfr., Bfr., And Wfr. Are as defined above, respectively.

도 2에서 보듯이, 사염화탄소 주사로 정상군(Normal)보다 음성대조군(NC)에서 증가된 활성을 보인 GST 활성은 털부처꽃 뿌리의 용매별 분획물을 투여한 대부분의 실험군들(Hfr., EAfr., Bfr., Wfr.)에서 완화된 것을 확인할 수 있었으며, 완화 정도는 실리마린 투여군(PC)과 같은 수준으로 효과적임을 알 수 있었다. 에텔 분획물 투여군(Efr.)에서도 음성대조군보다는 우수한 효과를 확인하였다.As shown in Figure 2, the GST activity showed increased activity in the negative control group (NC) than the normal group (Normal) by injection of carbon tetrachloride is the majority of the experimental groups administered the solvent-specific fractions of the hairy roots (Hfr., EAfr., Bfr., Wfr.) Was found to be alleviated, and the degree of relaxation was found to be as effective as the silymarin-administered group (PC). Etel fraction administration group (Efr.) Also confirmed a better effect than the negative control group.

실험예Experimental Example 3:  3: 털부처꽃의Buddha 50% 에탄올 추출물의  50% of ethanol extract 화학반응계에서의In a chemical reaction system 항산화작용 분석 Antioxidant Analysis

In vitro 반응계에서의 예비실험 결과(실험결과 생략)에 따라, 털부처꽃 뿌리의 최적 추출조건으로 선정한 85 ℃, 50% 에탄올 추출물을 조제하여 다음과 같이 화학반응계에서의 활성을 분석하였다. In According to the results of preliminary experiments in vitro (omitted from the experimental results), 85 ° C. and 50% ethanol extracts were selected as the optimal extraction conditions of hairy roots, and the activities in the chemical reaction system were analyzed as follows.

1. DCFDA(2',7'-dichlorofluorescin diacetate) 반응계에서의 ROS(reactive oxygen species, 활성산소종) 소거능 분석1. Analysis of ROS (reactive oxygen species) scavenging activity in DCFDA (2 ', 7'-dichlorofluorescin diacetate) system

3 개 농도로 준비된 시료와 대조물질(Trolox, Aldrich, 238813-1G)을 96 웰에 각 10 ㎕씩 분주하고, LPS(lipopolysaccharide)를 처리한 흰쥐의 간장 조직을 균질화 한 후 50 mM PBS로 100 배 희석하여 190 ㎕씩 분주한 후, 0.125 mM DCFDA 50 ㎕를 분주하여 5 분간 혼합한 다음, 형광광도계(Genios)를 이용하여 5 분 동안 485 ㎚에서의 excitation과 530 ㎚에서의 emission을 측정하였다, 이때, blank로는 50 mM PBS를 사용하였으며, 결과는 초당 blank의 Ex485nm/Em530nm에 대한 시료 3 개 각각의 농도에 대한 Ex485nm/Em530nm의 초당 변화량을 백분율로 나타낸 값의 평균을 구하여, 농도와 Ex485nm/Em530nm의 초당 변화량의 백분율 사이의 방정식을 구한 후 50% 감소되는 농도를 산출하였다.Samples prepared at three concentrations and 10 μl of control material (Trolox, Aldrich, 238813-1G) were dispensed into 96 wells each, and the liver tissues of rats treated with LPS (lipopolysaccharide) were homogenized and then 100-fold with 50 mM PBS. After diluting and dispensing 190 μl, 50 μl of 0.125 mM DCFDA was dispensed and mixed for 5 minutes, and then excitation at 485 nm and emission at 530 nm were measured for 5 minutes using a fluorophotometer (Genios). 50 mM PBS was used as a blank, and the results were obtained by averaging the percentage of change per second of Ex 485 nm / Em 530 nm per concentration for each of the three samples for a blank of Ex 485 nm / Em 530 nm per second. After calculating the equation between the percentage of change per second of Ex 485 nm / Em 530 nm , the concentration was reduced by 50%.

2. Peroxynitrite(ONOO-) 소거능 분석2. Peroxynitrite (ONOO -) scavenging analysis

3 개 농도의 시료를 준비한 후 96 웰 블랙 플레이트에 시료를 10 ㎕씩 분주하고, 로다민 완충액, 5 mM DTPA 및 DHR 123을 일정비율로 혼합한 DHR 혼합액을 180 ㎕, 그리고 200 μM peroxynitrie를 10 ㎕씩 분주한 후, 형광광도계에서 Ex485nm/Em535nm를 측정하였다. 결과는 DCFDA와 동일한 방법으로 산출하였다.After preparing three samples, 10 μl of the sample was dispensed into a 96 well black plate, 180 μl of the DHR mixture containing Rhodamine buffer, 5 mM DTPA, and DHR 123 at a constant ratio, and 10 μl of 200 μM peroxynitrie. After each aliquot , Ex 485 nm / Em 535 nm was measured with a fluorophotometer. The results were calculated in the same way as DCFDA.

3. 실험결과3. Experimental Results

실험결과는 아래 표 3에 나타낸다.The experimental results are shown in Table 3 below.

털부처꽃 뿌리(LSR)에서 조제된 50% 에탄올 추출물의 DCFDA 반응계에서의 활성산소(ROS) 및 peroxynitrite(ONOO-) 소거활성Lythrum hair root (LSR) with 50% of active oxygen in the reaction system of the ethanol extract of DCFDA (ROS) and peroxynitrite (ONOO -) prepared in the scavenging 추출물 & 대조군Extract & Control ROS 소거능 (SC50, ㎍/㎖)ROS scavenging activity (SC 50 , μg / ml) ONOO- 소거능(SC50, ㎍/㎖)ONOO - scavenging capacity (SC 50 , μg / ml) 털부처꽃 추출물Hairy Buddha Extract 2.42±0.032.42 ± 0.03 -23.3±5.4-23.3 ± 5.4 TroloxTrolox 3.43±0.023.43 ± 0.02 -- 페니실라민Penicillamine -- -43.1±5.6-43.1 ± 5.6

(1) 털부처꽃 뿌리의 50% 에탄올 추출물은 DCFDA 반응계에서의 활성산소 소거능이 2.42 ㎍/㎖로서 양성대조물질인 Trolox의 3.43 ㎍/㎖ 보다 우수한 활성을 보여 매우 효과적인 항산화작용을 나타내는 것을 확인하였다.(1) It was confirmed that 50% ethanol extract of the hairy root of Root-bloom was very effective in the antioxidant activity of 2.42 ㎍ / ml in DCFDA reaction system, showing better activity than 3.43 ㎍ / ml of Trolox, a positive control.

(2) 또한, peroxynitrie에 대한 소거능도 털부처꽃 뿌리의 50% 에탄올 추출물은 -23.3 ㎍/㎖로 나타났는데, 이값은 양성대조물질인 페니실라민의 -43.1 ㎍/㎖보다 다소 높은 값으로, 비교적 우수한 peroxynitrite 소거능을 보여주었다.(2) In addition, the scavenging activity of peroxynitrie was 50% ethanol extract of hairy root, -23.3 ㎍ / ml, which was somewhat higher than -43.1 ㎍ / ml of the positive control penicillamine. It showed peroxynitrite scavenging ability.

실험예Experimental Example 4:  4: 털부처꽃Hair bud 뿌리 50% 에탄올 추출물의 세포  Root 50% Ethanol Extract Cells 반응계에서의In the reaction system 활성 검정 Active black

1. YPEN1 세포에서의 활성산소 생성 저해 효과1. Inhibitory Effect of Reactive Oxygen Generation in YPEN1 Cells

소의 전립선에서 분리한 내피세포인 YPEN1 세포를 1.5×10-4 세포/웰로 96 웰에 분주하고 하룻밤 배양한 후, 배지를 버리고 PBS로 세척한 다음, 무혈청 배지를 150 ㎕ 가하고 3 개 농도의 털부처꽃 뿌리 50% 에탄올 추출물을 각각의 웰에 분주한 후1 시간 동안 배양하였다. 그 후, 활성산소 생성 유발물질인 t-BHT(t-buthyl hydroperoxide)를 최종 농도로 10 μM이 되도록 분주한 후 혼합하고 1 시간 배양, 배지 제거, PBS 세척한 다음 SFMedia를 180 ㎕ 첨가하고 형광염색 시약을 50 ㎕ 분주하여 형광광도계에서 Ex485nm/Em535nm를 측정하였다. 결과는 DCFDA에서와 동일한 방법으로 산출하였다.YPEN1 cells, endothelial cells isolated from bovine prostate, were seeded in 96 wells at 1.5 × 10 −4 cells / well, incubated overnight, discarded and washed with PBS, and 150 μl of serum-free medium was added. Buddha root 50% ethanol extract was dispensed into each well and incubated for 1 hour. Thereafter, t-BHT (t-buthyl hydroperoxide), which is an inducer of active oxygen generation, was dispensed to a final concentration of 10 μM, mixed, incubated for 1 hour, medium removed, washed with PBS, and 180 μl of SFMedia was added, followed by fluorescent staining. 50 μl of the reagent was dispensed to measure Ex 485 nm / Em 535 nm on a fluorophotometer. The results were calculated in the same way as in DCFDA.

2. BV2 세포에서의 산화질소(NO) 생성 저해 효과2. Inhibitory Effect of Nitric Oxide (NO) Production in BV2 Cells

BV2 세포를 DMEM 배지를 이용하여 1.0×106 세포/㎖로 조절한 후, 60 ㎜ 접시에 접종하고 추출물을 (0.8, 4.0, 및 20.0 ㎍/㎖)과 사이토카인 혼합물을 처리하고 16 시간 동안 배양하였다. 생성된 NO(Nitric oxide)의 양은 Griess 시약을 이용하여 Liang의 방법에 따라 시행하였다. 세포배양액 중에 존재하는 (NO2 -)의 형태로 측정하였으며, 세포 배양액 상등액 100 ㎕와 Griess 시약[0.1% N-(1-나프틸)에틸렌디아민.2HCl, 1% 설파닐아마이드 in 5% conc. H3PO4 in H2O] 100 ㎕를 혼합하여 96 웰에서 10분 동안 반응시킨 후 540 ㎚에서 흡광도를 측정하였으며, 아질산나트륨(NaNO2)을 표준품과 비교하여 NO 생성량을 확인하였다.BV2 cells were adjusted to 1.0 × 10 6 cells / ml with DMEM medium, then inoculated into 60 mm dishes and treated with extracts (0.8, 4.0, and 20.0 μg / ml) and cytokine mixture and incubated for 16 hours. It was. The amount of NO (Nitric oxide) produced was performed according to Liang's method using Griess reagent. Measured in the form of (NO 2 ) present in the cell culture, 100 μl of the cell culture supernatant and Griess reagent [0.1% N- (1-naphthyl) ethylenediamine. 2HCl, 1% sulfanylamide in 5% conc. After 100 μl of H 3 PO 4 in H 2 O was mixed and reacted in 96 wells for 10 minutes, the absorbance was measured at 540 nm. The amount of NO produced was confirmed by comparing sodium nitrite (NaNO 2 ) with a standard product.

3. SH-ST5Y 세포의 생존율 확인3. Confirmation of viability of SH-ST5Y cells

96 웰에 웰 당 2×104의 세포를 각각 첨가하고 1 개의 웰에는 세포 부유액 대신 배지만을 가해 흡광도 측정시 blank로 사용하였다. 물에 녹인 용액에 녹인 시료 용액은 원하는 농도의 10 배로 만들어 PBS로 희석하여 6 가지 농도로 20 ㎕씩 첨가하였으며, 세포 부유액 마지막 웰에는 시료 대신 PBS를 첨가하여 100% 생존군으로 하였다. 검체 투여가 끝난 플레이트를 37 ℃, 5% CO2 배양기에 48 시간 배양한 후 2 ㎎/㎖ MTT(3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) 용액 50 ㎕/웰을 가하고 다시 4 시간 배양하였다. 배양 종료시 3,000 rpm에서 5 분간 원심분리한 후 배지를 제거하고 DMSO(dimethylsulfoxide) 150 ㎕/웰을 가하여 포르마잔 결정을 녹이고 균일하게 만든 다음, ELIZA 판독기(TECHAN, USA)로 OD540 값을 측정하였다. 대조군과 비교한 실험군의 세포생존율은 실험군의 평균 OD540 값을 구하여 대조군의 평균 OD540 값에 대한 백분율로 나타내었다.2 × 10 4 cells per well were added to 96 wells, and only one medium was used as a blank for absorbance measurement. A sample solution dissolved in a solution dissolved in water was made 10 times the desired concentration, diluted with PBS, and 20 μl of each solution was added to each of the six wells. After incubating the sample plate for 48 hours at 37 ° C and 5% CO 2 incubator, 50 µl of 2 mg / ml MTT (3- (4,5-dimethylthiazol-2-yl) -2,5-diphenyltetrazolium bromide) solution / Well was added and incubated again for 4 hours. At the end of the culture, centrifuge at 3,000 rpm for 5 minutes, remove the medium, add 150 μl / well of DMSO (dimethylsulfoxide) to dissolve and homogenize the formazan crystals, and then use IZ 540 with ELIZA reader (TECHAN, USA). The value was measured. The cell survival rate of the experimental group compared to the control group was OD 540 The values were obtained and expressed as a percentage of the mean OD 540 value of the control.

4. 실험결과4. Experimental Results

(1) 도 3은 털부처꽃 뿌리의 50% 에탄올 추출물(LSR, 40, 200, 1000 ppm 처리)의 YPEN1 세포에서 t-BHT로 유도된 활성산소(ROS) 생성 저해 효과를 나타낸 그래프이다.(1) Figure 3 is a graph showing the inhibitory effect of t-BHT-induced reactive oxygen (ROS) production in YPEN1 cells of 50% ethanol extract (LSR, 40, 200, 1000 ppm treatment) of hairy roots.

도 3에서 보듯이, 털부처꽃 뿌리의 50% 에탄올 추출물은 소의 전립선에서 분리한 내피세포(YPEN1 세포)에 대해 40, 200 및 1,000 ppm 농도에서 t-BHT만을 처리한 음성대조군(111.4)에 비해 정상 수준(54.5, 54.5 & 62.8)으로 활성산소의 생성을 감소시키는 것으로 확인되었다. 이는 음성대조군보다 43.6∼51.1%의 활성산소 생성 감소 효과를 나타낸 것으로서, 화학반응계에서의 효과가 동물세포에서도 매우 효과적으로 작용하는 것을 알 수 있었다.As shown in Fig. 3, the 50% ethanol extract of the hairy irises was normal compared to the negative control group (111.4) treated only with t-BHT at 40, 200 and 1,000 ppm concentrations for endothelial cells (YPEN1 cells) isolated from bovine prostate. Levels (54.5, 54.5 & 62.8) have been shown to reduce the production of free radicals. This showed 43.6-51.1% less active oxygen production than the negative control group, and the effect in the chemical reaction system was found to be very effective in animal cells.

(2) 도 4는 털부처꽃 뿌리의 50% 에탄올 추출물(LSR, 1, 10, 50, 100, 1000 ppm 처리)의 BV2 세포에서 LPS로 유도된 NO 생성 저해 활성을 나타낸 그래프이다.(2) FIG. 4 is a graph showing LPS-induced NO production inhibitory activity in BV2 cells of 50% ethanol extract (LSR, 1, 10, 50, 100, 1000 ppm treatment) of hairy roots.

도 4에서 보듯이, 털부처꽃 뿌리의 50% 에탄올 추출물은 BV2 세포에서의 NO 생성에 대해서도 대체로 농도 의존적으로 감소시키는 것을 확인하였으며, 1,000 ppm 농도에서 가장 많은 23%의 산화질소 감소 효과가 확인되었다.As shown in Figure 4, it was confirmed that the 50% ethanol extract of the hairy roots of the roots generally reduced in concentration depending on the NO production in BV2 cells, the most 23% reduction of nitrogen oxide was confirmed at 1,000 ppm concentration.

(3) 털부처꽃 뿌리 50% 에탄올 추출물이 동물세포에서 효과를 발휘하는 것이 세포에 대한 독성에 따른 것인지를 확인하고자 MTT 분석을 수행하였으며, 도 5는 털부처꽃 뿌리의 50% 에탄올 추출물(LSR, 1, 10, 50, 100, 1000 ppm 처리)의 동물 신경세포(SH-SY5Y) 생존율에 대한 효과를 나타낸 그래프이다.(3) MUT analysis was performed to determine whether 50% ethanol extract of hairy roots exerts the effect on animal cells according to toxicity to cells. FIG. 5 shows 50% ethanol extract of hairy roots (LSR, 1). , 10, 50, 100, 1000 ppm treatment) is a graph showing the effect on the survival rate of animal neurons (SH-SY5Y).

도 5에서 보듯이, 털부처꽃 추출물은 SH-ST5T 세포의 생존을 유의하게 감소시키지 않았으며, 오히려 농도가 1,000 ppm일 때는 세포의 생존을 대조군보다 증가시키는 것을 확인하였다.As shown in FIG. 5, the hair hyacinth extract did not significantly reduce the survival of SH-ST5T cells. Rather, when the concentration was 1,000 ppm, it was confirmed that the survival of the cells was increased compared to the control group.

실험예Experimental Example 5:  5: 털부처꽃의Buddha 50% 에탄올 추출물의  50% of ethanol extract 간섬유화Liver fibrosis 저해 활성 검정 Inhibitory Activity Assay

1. 동물실험 계획1. Animal experiment plan

털부처꽃 뿌리의 50% 에탄올 추출물이 섬유화 유도된 흰쥐 간장에 대해 저해활성을 나타내는 지를 확인하기 위한 실험을 수행하였다.Experiments were conducted to determine whether 50% ethanol extract of hairy roots had inhibitory activity against fibrosis-induced rat liver.

실험동물로는 체중 100 g 전후의 Sprague Dawley계 수컷 흰쥐를 사용하여, 각 실험군 당 8 마리씩 무작위로 배정하였다. 실험군은 아래의 표 4와 같이 구성하였으며, 털부처꽃 뿌리의 50% 에탄올 추출물 및 양성 대조물질 투여량은 0.125, 0.25 및 0.5 g/체중 ㎏/래트/일(1 회/일, 5 회/주, 5 주간 투여)로 하였다. 독성 유발은 40% CCl4을 1 ㎖/체중 kg/래트로 옥수수유 1 ㎖에 혼합하여 복강 주사하였다. 사료는 시판 고형사료(샘타코)를 사용하였고, 사육조건 및 혈청 분리는 실험예 2와 동일한 조건으로 수행하였다.As experimental animals, Sprague Dawley male rats weighing about 100 g were randomly assigned to 8 animals in each experimental group. The experimental group was configured as shown in Table 4 below, and the 50% ethanol extract and the positive control doses of the hairy roots were 0.125, 0.25 and 0.5 g / kg body weight / rat / day (once / day, five times / week, 5 weeks of administration). Toxicity induction was intraperitoneally injected with 1 ml / kg body weight / rat of 40% CCl 4 mixed with 1 ml of corn oil. Commercial solid feed (Sam taco) was used, and breeding conditions and serum separation were performed under the same conditions as in Experimental Example 2.

정상군Normal 음성대조군Negative Control 양성 대조군Positive control 털부처꽃 뿌리 추출물 투여군Hair Buddha Root Extract Administration Group 투여물질Substance 담체carrier 담체carrier 담체+실리마린 (0.125, 0.25, 0.5 g/kg)Carrier + Silymarin (0.125, 0.25, 0.5 g / kg) 담체+추출물 (0.125, 0.25, 0.5 g/kg)Carrier + Extract (0.125, 0.25, 0.5 g / kg) 사염화탄소 주사Carbon tetrachloride injection 무처리 No treatment 처리process 처리process 처리process

2. 간장으로부터 균질액 조제2. Preparation of homogenate from soy sauce

과산화물질(TBARS, thiobarbituric acid reactive substance) 및 글루타치온의 함량을 분석하기 위해, 적출된 간장 중량의 4 배 부피의 0.1M 인산나트륨 완충액(pH 7.4)으로 teflon homogenizer에서 균질화시켜, 간장으로부터 균질액을 얻었다.In order to analyze the contents of thiobarbituric acid reactive substance (TBARS) and glutathione, homogenates were obtained from the liver by homogenizing in a teflon homogenizer with 0.1 M sodium phosphate buffer (pH 7.4) of 4 times the volume of the extracted soy. .

3. 간장의 지질과산화물질(TBARS, thiobarbituric acid reactive substance)의 함량 분석3. Analysis of thiobarbituric acid reactive substance (TBARS) in liver

간장 균질액 2 ㎖를 25 ㎖ 크기의 원심분리관에 담고 10% TCA 수용액 3 ㎖와 0.8% BHT를 함유하는 헥산 2.5 ㎖를 순차적으로 가해 30 초 동안 혼합한 후 600×g(300 rpm)로 3 분 동안 원심분리시키고, 상층의 헥산층을 버린 다음 수층을 5% TCA로 10 ㎖ 정용하였다. 이 중 2.5 ㎖를 취해 뚜껑이 있는 시험관에 분주하고 0.8% TBA 1.5 ㎖를 가한 다음, 통상적인 방법에 따라 끓는 물에서 15 분 동안 반응시킨 후 급냉하여 521.5 ㎚에서 흡광도를 측정하였다. 결과는 표준물질인 MDA에 의해 작성된 검량선 식에 따라 산출하였다.2 ml of soy homogenate was added to a 25 ml centrifuge tube, and 3 ml of 10% TCA aqueous solution and 2.5 ml of hexane containing 0.8% BHT were added sequentially, mixed for 30 seconds, and then mixed at 600 × g (300 rpm). Centrifuged for minutes, discarded the hexane layer of the upper layer, and the aqueous layer was allowed to settle 10 ml with 5% TCA. 2.5 ml of this solution was taken into a test tube with a lid, 1.5 ml of 0.8% TBA was added thereto, and then reacted in boiling water for 15 minutes according to a conventional method, followed by quenching and absorbance at 521.5 nm. The results were calculated according to the calibration curve formulated by MDA, the standard.

4. 간장의 항산화물질 함량의 분석4. Analysis of Antioxidant Content in Soy Sauce

총 글루타치온 함량은, 간장으로부터 조제된 균질액 1 ㎖에 4% 설포살리실산을 동량 가하여 제단백하고, 얻어진 상등액에 디설파이드 시약(5,5'-dithiobis(2-nitro benzoic acid) 39.636 ㎎을 0.1M 인산나트륨 완충액(pH 8.0) 1ℓ에 녹여 제조) 2.7 ㎖을 가하여 얻어진 청색 화합물을 421 ㎚에서 측정하고, 결과는 글루타치온 표준품을 사용한 검량선에 흡광도를 대입하여 산출하였다.The total glutathione content was deproteinized by adding an equal amount of 4% sulfosalicylic acid to 1 ml of homogenate prepared from soy sauce, and 39.636 mg of disulfide reagent (5,5'-dithiobis (2-nitro benzoic acid)) was added 0.1M phosphoric acid to the obtained supernatant. The blue compound obtained by adding 2.7 ml of sodium buffer (pH 8.0) dissolved in 1 L was measured at 421 nm, and the result was calculated by substituting absorbance into the calibration curve using glutathione standard.

산화형 글루타치온(GSSG)은 원심분리한 상등액 1 ㎖와 1 M 2-비닐 피리딘 20 ㎕를 혼합하여 상온에서 60 분간 방치한 후 총 글루타치온 함량 분석과 동일하게 실험하였다. 환원형 글루타치온(GSH)의 함량은 총 글루타치온의 함량에서 산화형 글루타치온의 함량을 뺀 것으로 하였고, 결과는 이들의 비(GSH/GSSG)로서 나타내었다.Oxidized glutathione (GSSG) was mixed with 1 ml of the centrifuged supernatant and 20 µl of 1 M 2-vinyl pyridine, and left at room temperature for 60 minutes. The content of reduced glutathione (GSH) was calculated by subtracting the content of oxidized glutathione from the total glutathione content, and the results are expressed as their ratio (GSH / GSSG).

5. 간장의 GST 활성 분석5. GST activity analysis of liver

실험예 2에 명기한 것과 동일한 방법으로 수행하였다.It carried out by the same method as specified in Experimental Example 2.

6. 간장의 콜라겐 함량 분석6. Analysis of Collagen Content in Soy Sauce

약 100 ㎎의 간조직을 6N HCl 2 ㎖을 가해 110 ℃에서 24 시간 동안 가수분해하고, 50 ℃ 수욕에서 증발 건조시킨 후 남은 잔사를 증류수 10 ㎖로 녹여 0.45 ㎛ 밀리포어 필터로 여과하였다. 그 중 1 ㎖을 새로 조제한 1.4% 클로라민-T 용액 1 ㎖과 혼합하고 상온에서 20 분간 방치한 후 19% 과염소산 1 ㎖과 혼합하여 상온에서 5 분간 반응시킨 다음, 최종적으로 새로 조제한 메틸셀로솔브 중 20% p-디메틸아미노벤즈알데히드(혹은 에틸렌글리콜 모노메틸 에테르) 1 ㎖을 가하였다. 이 반응액을 60 ℃의 수욕에서 20 분간 반응시킨 후 냉각하고 560 ㎚에서 흡광도를 측정하였다. 결과는 표준품(하이드록시프롤린)를 사용하여 검량선을 작성한 후 얻었으며 ㎍/조직 100 ㎎으로 표기하였다.About 100 mg of liver tissue was added with 2 ml of 6N HCl, hydrolyzed at 110 ° C. for 24 hours, evaporated to dryness in a 50 ° C. water bath, and the remaining residue was dissolved in 10 ml of distilled water and filtered through a 0.45 μm Millipore filter. 1 ml of the mixture was mixed with 1 ml of freshly prepared 1.4% chloramine-T solution, left at room temperature for 20 minutes, mixed with 1 ml of 19% perchloric acid, and reacted at room temperature for 5 minutes, and finally in the newly prepared methyl cellosolve. 1 ml of 20% p-dimethylaminobenzaldehyde (or ethylene glycol monomethyl ether) was added. The reaction solution was reacted for 20 minutes in a 60 ° C. water bath, cooled, and the absorbance measured at 560 nm. The results were obtained after a calibration curve was prepared using a standard product (hydroxyproline) and expressed in μg / tissue 100 mg.

7. 면역조직화학분석법에 의한 간장의 콜라겐 감소효과 분석7. Analysis of collagen reduction effect of liver by immunohistochemistry

(1) 래트 간 적출(1) Extraction between Rats

모든 실험군에서 동일한 위치의 간엽(liver lobe)을 적출한 후 10% 완충 포르말린 용액(0.1M PBS, pH 7.0)에 담가 24∼48 시간 방치한 다음, 표본을 PBS로 세척하고 단계적인 알코올(graded alcohol; 50%→75%→90%→95%→100%)로 탈수한 후 파라핀에 묻어 블록을 얻고, 이것을 마이크로톰(microtome)을 이용해 5 ㎛의 절편을 얻었다.After removing the lobe of the same position in all the experimental groups, soaked in 10% buffered formalin solution (0.1M PBS, pH 7.0) and left for 24 to 48 hours, the sample was washed with PBS and graded alcohol 50% → 75% → 90% → 95% → 100%), and then immersed in paraffin to obtain a block, which was then sliced into 5 μm using a microtome.

(2) 면역조직화학분석에 의한 흰쥐 간장의 콜라겐 감소 효과 확인(2) Confirmation of collagen reduction effect in liver of rat by immunohistochemical analysis

PAP(peroxidase anti-peroxidase) 방법을 이용하여, 하이브리드화(hybridization)을 위해 위의 파라핀에 묻은 5 ㎛ 절편이 부착된 슬라이드로부터 크실렌으로 파라핀을 제거하고 일련의 단계적인 에탄올 용액(100%→90%→75%→50%→0%)을 통해 가수 한 후 증류수로 세척하였다. 내인성 퍼옥시다제 활성의 파괴를 위해 0.3% 과산화수소를 함유하는 메탄올로 4 ℃에서 10 분간 처리하고 PBS에 녹인 5% 소 혈청 알부민(BSA; bovine serum albumin)으로 4 ℃에서 30 분간 처리하였다. 절편은 1% 소 혈청 알부민을 함유하는 인산 완충 생리식염수(PBS; phosphate buffered saline)에서 희석된 마우스 유래 항체인 모노클로날 항-콜라겐 타입 Ⅲ(monoclonal anti-collagen, type Ⅲ, Sigma C7805, clone FH-7A, 희석 1:2,000)로 상온에서 1 시간 배양하고 PBS로 세척하였다. 희석된 염소 유래 이차 항-마우스 IgG (Fab 특이적) 항체(secondary anti-mouse IgG (Fab specific) antibody, Sigma M6898, 1:1,000)와 함께 상온에서 30 분간 배양하고 PBS로 세척한 후, 마우스 유래 PAP 복합체(Sigma P2416 1:500)와 함께 상온에서 1 시간 배양하였다. 이것을 PBS로 세척한 후 0.05% 3,3'-디아미노벤지딘 염산 용액(DAB, Sigma D4418) 기질 크로모겐(substrate chromogen)으로 상온에서 5 분간 반응시키고 물로 세척한 다음 헤마톡실린으로 대조염색(counter staining)하였다. 다음에 물로 세척한 후 마운팅 배지(mounting medium)를 사용하여 마운팅하고 커버 슬립으로 봉하였다. 건조된 슬라이드 표본으로 광학현미경에서 콜라겐 생성 정도를 관찰하였다.Using the peroxidase anti-peroxidase (PAP) method, paraffin was removed with xylene from slides with 5 μm sections attached to the above paraffins for hybridization, followed by a series of staged ethanol solutions (100% → 90%). → 75% → 50% → 0%) and then rinsed with distilled water. To destroy endogenous peroxidase activity, the mixture was treated with methanol containing 0.3% hydrogen peroxide for 10 minutes at 4 ° C. and treated with 5% bovine serum albumin (BSA) in PBS for 30 minutes. Sections were monoclonal anti-collagen, type III, Sigma C7805, clone FH, a mouse-derived antibody diluted in phosphate buffered saline (PBS) containing 1% bovine serum albumin. -7A, dilution 1: 2,000) and incubated at room temperature for 1 hour and washed with PBS. Incubated with diluted goat-derived secondary anti-mouse IgG (Fab specific) antibody (Sigma M6898, 1: 1,000) at room temperature for 30 minutes, washed with PBS, and then mouse-derived. Incubated with PAP complex (Sigma P2416 1: 500) at room temperature for 1 hour. This was washed with PBS, reacted with 0.05% 3,3'-diaminobenzidine hydrochloric acid solution (DAB, Sigma D4418) substrate chromogen at room temperature for 5 minutes, washed with water and counterstained with hematoxylin. staining). It was then washed with water and then mounted using a mounting medium and sealed with a cover slip. The degree of collagen production was observed on a light microscope with dried slide specimens.

8. 조직학적 분석에 의한 흰쥐 간장의 콜라겐 감소 효과 분석8. Analysis of Collagen Reduction Effect of Rat Liver by Histological Analysis

위 실험예 5의 7에 기술한 바와 같이, 래트 간의 파라핀 블록을 조제한 후 슬라이드에 부착된 5 ㎛의 절편으로부터 크실렌 처리로 파라핀을 제거하고 일련의 단계적인 에탄올 용액(100%→90%→75%→50%→0%)을 통해 가수하였다. 0.1% 시리우스 레드(sirius red)로 1차 염색한 후 세척하고 패스트 그린(fast green)으로 대조염색(counter staining)한 후, 일련의 단계적인 에탄올 용액(50%→75%→90%→95%→100%) 및 크실렌으로 탈수한 다음 마운팅하고 커버 슬립으로 봉하였다. 건조된 슬라이드 표본으로 광학현미경에서 콜라겐 생성 정도를 관찰하였다.As described in Experiment 5 of Example 7, paraffin blocks were prepared between the rats, and then paraffin was removed from the 5 μm sections attached to the slides by xylene treatment, and a series of stepwise ethanol solutions (100% → 90% → 75%). → 50% → 0%). After primary dyeing with 0.1% sirius red, washed and counter staining with fast green, a series of staged ethanol solutions (50% → 75% → 90% → 95%) 100%) and dehydrated with xylene and then mounted and sealed with cover slip. The degree of collagen production was observed on a light microscope with dried slide specimens.

9. 실험결과 9 . Experiment result

(1) 흰쥐 간장 중의 지질과산화물질 생성 감소에 대한 효과(1) Effects on Reduction of Lipid Peroxide Production in Rat Liver

도 6은 털부처꽃 뿌리의 50% 에탄올 추출물(LSR, 0.125, 0.25, 0.5 g/㎏ 투여)의, 사염화탄소로 간섬유화가 유도된 흰쥐 간장 중 지질과산화물질(TBARS) 생성 감소 효과를 나타낸 그래프이다. 여기에서, Normal은 사염화탄소 무처리 정상군, NC는 사염화탄소 처리 대조군, Sil-0.125, Sil-0.25, Sil-0.5은 각각 사염화탄소 및 실리마린 0.125, 0.25, 0.5 g/㎏ 투여 대조군, LSR-0.125, LSR-0.25, LSR-0.5는 각각 사염화탄소 및 털부처꽃 뿌리 50% 에탄올 추출물 0.125, 0.25, 0.5 g/㎏ 투여군을 의미한다.FIG. 6 is a graph showing the effect of 50% ethanol extract (LSR, 0.125, 0.25, 0.5 g / kg administration) of hairy buds roots on the reduction of lipid peroxide (TBARS) production in liver liver induced by carbon tetrachloride. Here, Normal is a carbon tetrachloride-free normal group, NC is a carbon tetrachloride-treated control group, Sil-0.125, Sil-0.25, Sil-0.5 is carbon tetrachloride and silymarin 0.125, 0.25, 0.5 g / kg administration control, LSR-0.125, LSR- 0.25, LSR-0.5 refers to the administration of carbon tetrachloride and hairy root 50% ethanol extract 0.125, 0.25, 0.5 g / kg respectively.

도 6에서 보듯이, 털부처꽃 뿌리의 50% 에탄올 추출물을 사염화탄소로 간섬유화가 유도된 흰쥐 모델에 0.125 g/㎏, 0.25 g/㎏ 및 0.5 g/㎏으로 투여한 결과, 털부처꽃 뿌리 추출물은 각각 7.3, 8.1 및 5.8 ㎍/g 조직의 과산화물질 함량을 보였다. 이는, 음성대조군(9.1 ㎍/g 조직, 100%)과 비교하였을 때, 간장의 지질과산화물질 생성을 11∼36.3% 감소시킨 것으로, 양성 대조물질인 실리마린을 투여하였을 때의 과산화물질 함량 9.1, 6.6 및 6.6 ㎍/g 조직의 감소 효과인 0∼27.5% 보다 더 효과적인 것이다.As shown in Figure 6, 50% ethanol extract of the hairy iris flower root was administered 0.125 g / kg, 0.25 g / kg and 0.5 g / kg in rat liver fibrosis induced with carbon tetrachloride, the hairy iris flower extract was Peroxide contents of 7.3, 8.1 and 5.8 μg / g tissues were shown. Compared with the negative control group (9.1 μg / g tissue, 100%), hepatic lipid peroxide production was reduced by 11 to 36.3%, and the peroxide content when the positive control silymarin was administered 9.1, 6.6 And 0-27.5%, which is a reducing effect of 6.6 μg / g tissue.

(2) 흰쥐 간장 중의 항산화물질 유지 효과(2) Antioxidant Maintenance Effect in Liver of Rat

도 7은 털부처꽃 뿌리의 50% 에탄올 추출물(LSR, 0.125, 0.25, 0.5 g/㎏ 투여)의, 사염화탄소로 간섬유화가 유도된 흰쥐 간장 중 항산화물질 함량 유지 효과를 나타낸 그래프이다.Figure 7 is a graph showing the effect of maintaining the antioxidant content in liver liver fibrillation induced by carbon tetrachloride of 50% ethanol extract (LSR, 0.125, 0.25, 0.5 g / kg administration) of hairy roots.

도 7에서 보듯이, 사염화탄소로 간섬유화가 유도된 흰쥐 모델에 털부처꽃 뿌리의 추출물을 0.125 g/㎏, 0.25 g/㎏ 및 0.5 g/㎏ 투여한 결과, 각각 6.1, 7.8 및 12.5의 GSH/GSSG 비를 나타내었다. 이는, 음성대조군의 2.2를 100%으로 하였을 때와 비교하여 277∼568 % 증가한 것으로, 양성 대조물질인 실리마린의 GSH/GSSG 비 4.9, 7.5, 6.5의 증가 효과인 223∼341 % 보다 월등히 우수한 것이다.As shown in Fig. 7, as a result of administering 0.125 g / kg, 0.25 g / kg and 0.5 g / kg of the extract of hairy roots to the rat model induced liver fibrosis with carbon tetrachloride, GSH / GSSG of 6.1, 7.8 and 12.5, respectively Rain was shown. This is an increase of 277 to 568% compared with 2.2 of the negative control group at 100%, which is much better than the increase effect of the GSH / GSSG ratio of 4.9, 7.5 and 6.5 of the positive control silymarin, 223 to 341%.

(3) 흰쥐 간장 중의 무독화 효소(GST) 활성 완화 효과(3) Efficacy of Detoxifying Enzyme (GST) Activity in Rat Liver

도 8은 털부처꽃 뿌리의 50% 에탄올 추출물(LSR, 0.125, 0.25, 0.5 g/㎏ 투여)의, 사염화탄소로 간섬유화가 유도된 흰쥐 간장 중의 무독화효소(GST) 활성 완화 효과를 나타낸 그래프이다.8 is a graph showing the effect of detoxifying enzyme (GST) activity in rat liver induced with hepatic fibrosis with carbon tetrachloride of 50% ethanol extract (LSR, 0.125, 0.25, 0.5 g / kg administration) of hairy roots.

도 8에서 보듯이, 털부처꽃 뿌리 추출물을 0.125 g/㎏, 0.25 g/㎏ 및 0.5 g/㎏ 투여한 결과, 각각 5.2, 4.9 및 4.8 μM conjugated DNCB/㎎ 단백질/분의 GST 활성을 나타내었다. 이는, 음성대조군의 5.3 μM conjugated DNCB/㎎ 단백질/분을 100%로 하였을 때, 정상대조군 수준으로 각각 1.9%, 8.5% 및 9.4% 완화된 활성을 보인 것으로, 양서 대조물질인 실리마린에서의 활성인 5.2, 5.0 및 5.1 μM conjugated DNCB/㎎ 단백질/분의 완화 효과인 1.9%, 5.7%, 3.7% 보다 효과적인 것이다.As shown in FIG. 8, administration of hairy root extract of 0.125 g / kg, 0.25 g / kg and 0.5 g / kg showed GST activity of 5.2, 4.9 and 4.8 μM conjugated DNCB / mg protein / min, respectively. This resulted in 1.9%, 8.5%, and 9.4% relaxation of normal control level when the 5.3 μM conjugated DNCB / mg protein / min of the negative control group was 100%, which is active in the amphibian control silymarin. It is more effective than 1.9, 5.7, and 3.7% of the mitigating effects of 5.2, 5.0, and 5.1 μM conjugated DNCB / mg protein / min.

(4) 흰쥐 간장 중의 콜라겐 생성 완화 효과(4) Relaxation Effect of Collagen Production in Rat Liver

① 총콜라겐 함량의 정량을 통한 콜라겐 생성 감소 효과 확인① Confirmation of collagen production reduction effect through quantification of total collagen content

도 9는 털부처꽃 뿌리의 50% 에탄올 추출물(LSR, 0.125, 0.25, 0.5 g/㎏ 투여)의, 사염화탄소로 간섬유화가 유도된 흰쥐 간장 중 콜라겐 함량 감소 효과를 나타낸 그래프이다.Figure 9 is a graph showing the effect of reducing collagen content in rat liver induced fibrosis with carbon tetrachloride of 50% ethanol extract (LSR, 0.125, 0.25, 0.5 g / kg administration) of hairy roots.

도 9에서 보듯이, 털부처꽃의 뿌리의 추출물을 0.125 g/㎏, 0.25 g/㎏ 및 0.5 g/㎏의 양으로 간섬유화 유도 흰쥐에 5 주간 투여한 후 적출한 간장의 콜라겐을 L-하이드록시프롤린로 분해한 다음 총 콜라겐의 함량을 분석한 결과, 각각 9.6, 5.3 및 10.1 ㎍/100 ㎎ 조직의 L-하이드록시프롤린 함량을 나타내었다. 이는, 음성대조군의 17.8 ㎍/100 ㎎ 조직에 대해 각각 46.1%, 70.2% 및 43.3% 감소한 것으로, 양성 대조물질인 실리마린의 9.7, 15.3 및 13.4 ㎍/100 ㎎ 조직의 감소 효과인 45.5%, 14.0% 및 24.7% 보다 매우 우수한 콜라겐 생성 저해능을 나타낸 것으로 확인되었다.As shown in Figure 9, the extract of the root of the hairy iris flower was administered to liver fibrosis-induced rats in amounts of 0.125 g / kg, 0.25 g / kg and 0.5 g / kg for 5 weeks, and then the collagen of the extracted liver was L-hydroxy. Analysis of the total collagen content after digestion with proline showed L-hydroxyproline content of 9.6, 5.3 and 10.1 μg / 100 mg tissues, respectively. This is a decrease of 46.1%, 70.2% and 43.3% for the 17.8 μg / 100 mg tissues of the negative control group, respectively, and 45.5% and 14.0%, which is the reduction effect of 9.7, 15.3 and 13.4 μg / 100 mg tissues of the positive control silymarin. And 24.7% showed much better collagen production inhibition.

② 면역조직화학분석법(Immunohistochemistry)에 의한 콜라겐 생성 감소 효과 확인② Confirmation of collagen production reduction effect by immunohistochemistry

도 10은 면역조직화학분석에 의한 털부처꽃 뿌리의 50% 에탄올 추출물(LSR, 0.125, 0.25, 0.5 g/㎏ 투여)의 흰쥐 간장 섬유화지표물질(콜라겐) 감소 효과를 보여주는 배율 ×100의 현미경사진이다.FIG. 10 is a micrograph of magnification × 100 showing the effect of reducing 50% ethanol extract (LSR, 0.125, 0.25, 0.5 g / kg) of rat hepatic fibrosis marker (collagen) by immunohistochemical analysis. .

도 10에서 보면, 현미경으로 관찰하였을 때, ①의 결과와 마찬가지로 털부처꽃 뿌리의 50% 에탄올 추출물은 0.25 및 0.5 g/㎏ 투여시 투여량에 의존적으로 갈색의 콜라겐과 두 차례의 항체, PAP complex 및 DAB chromogen과의 반응물이 음성대조군(NC, negative control)에 비해 감소하였으며, 이는 실리마린을 투여한 경우보다 우수한 것을 확인할 수 있었다.10, when observed under a microscope, 50% ethanol extract of the hairy root of the hairy roots, as in the results of ①, brown collagen and two antibodies, PAP complex and dose-dependently at 0.25 and 0.5 g / kg Reaction with DAB chromogen was reduced compared to the negative control (NC, negative control), which was confirmed to be superior to the silymarin administration.

③ 조직학적 분석법(Histology)에 의한 콜라겐 생성 감소 효과 확인③ Confirmation of collagen production reduction effect by histology

도 11은 조직학적 분석에 의한 털부처꽃 뿌리의 50% 에탄올 추출물(LSR, 0.125, 0.25, 0.5 g/㎏ 투여)의 흰쥐 간장 섬유화 감소 효과를 보여주는 배율 ×100의 현미경사진이다.FIG. 11 is a micrograph of magnification × 100 showing the effect of reducing 50% ethanol extract (LSR, 0.125, 0.25, 0.5 g / kg) of rat hepatic fibrosis in hairy roots by histological analysis.

모든 콜라겐 단백질에 특이적으로 반응하는 염색 시약인 시리우스 레드(Sirius red)와 그 대조 염색 시약을 처리하여 조직학적인 방법으로, 털부처꽃 뿌리의 50% 에탄올 추출물의 간섬유화가 유도된 흰쥐에서의 콜라겐 생성 감소 효과를 확인하였다. 도 11에서 보듯이, 털부처꽃 뿌리 추출물은 투여량이 증가할수록 총 콜라겐을 나타내는 적갈색의 색소침착 부위가 음성대조군에 비하여 현저히 감소하는 것을 확인할 수 있었으며, 이는 양성 대조물질인 실리마린 보다도 매우 우수하였다.Collagen production in rats induced liver fibrosis of 50% ethanol extracts of hairy roots by treatment with sirius red, a staining reagent that reacts specifically to all collagen proteins, and its control staining agent The reduction effect was confirmed. As shown in FIG. 11, the hair root extract was significantly reduced in red-brown pigmentation site showing total collagen as compared to the negative control group as the dose was increased, which was much better than that of the positive control silymarin.

본 발명의 실험예에서 얻어진 결과들은 SAS program의 Duncan's multiple range test에 의해 P<0.05의 수준에서 유의성을 검정하였다.The results obtained in the experimental example of the present invention was tested for significance at the level of P <0.05 by Duncan's multiple range test of the SAS program.

위 실시예 1과 2, 그리고 실험예 1 내지 5의 결과를 종합할 때, 털부처꽃 뿌리의 추출물과 분획물은 in vitro 화학반응계, 세포 반응계 및 간섬유화 동물 모델에서, 알콜을 포함한 약물에 의한 간장의 손상에 대하여 매우 효과적인 항산화 및 간 섬유화 저해 활성을 나타낸다고 할 수 있다. 더욱이, 이러한 효과는 시판 간장약인 실리마린 보다 우수하여, 본 발명의 털부처꽃 뿌리 추출물은 실리마린을 대체할 수 있는 식물 유래 천연 간 보호제로서 가능성이 매우 높다고 본다.Above Examples 1 and 2, and when these results of Experimental Example 1-5, the extract and fraction of the hair roots is in Lythrum In vitro chemical reaction system, cell response system and liver fibrosis animal model, it can be said that it shows the antioxidant and liver fibrosis inhibitory activity which is very effective against the damage of liver by drug including alcohol. Moreover, this effect is superior to the commercially available soy sauce silymarin, and therefore, the hair-blowing root extract of the present invention is highly likely as a plant-derived natural liver protectant that can replace silymarin.

이상에서 살펴본 바와 같이, 본 발명의 털부처꽃 뿌리의 추출물과 분획물은 항산화 활성과 간장 섬유화 저해 효능이 우수하여, 항산화 작용 및 간보호 기능성을 갖는 의약품 및 건강기능식품 소재로서 산업화가 가능하다.As described above, the extracts and fractions of the hair bud root of the present invention is excellent in antioxidant activity and hepatic fibrosis inhibitory effect, it can be industrialized as a medicine and health functional food material having antioxidant activity and hepatoprotective function.

Claims (5)

털부처꽃(Lythrum salicaria) 뿌리의 추출물을 유효성분으로 포함하는 간경화 예방 또는 치료용 약제학적 조성물.A pharmaceutical composition for preventing or treating liver cirrhosis, comprising an extract of the root of Lythrum salicaria as an active ingredient. 제 1 항에 있어서, 상기 추출물은 조성물 전체에 대하여 0.001∼99.999 중량%인 것을 특징으로 하는 간경화 예방 또는 치료용 약제학적 조성물.According to claim 1, wherein the extract is a liver cirrhosis prevention or treatment pharmaceutical composition, characterized in that 0.001 to 99.999% by weight of the total composition. 제 1 항에 있어서, 상기 추출물에는 분획물이 포함되고, 추출물과 분획물의 배합비율은 중량비로 99.999:0.001 내지 50:50인 것을 특징으로 하는 간경화 예방 또는 치료용 약제학적 조성물.The method of claim 1, wherein the extract comprises a fraction, the ratio of the extract and the fraction of the liver cirrhosis preventive or therapeutic pharmaceutical composition, characterized in that the weight ratio of 99.999: 0.001 to 50:50. 제 3 항에 있어서, 분획물은 헥산, 에텔, 에틸아세테이트 및 부탄올로부터 선택되는 유기용매 분획물인 것을 특징으로 하는 간경화 예방 또는 치료용 약제학적 조성물.4. The pharmaceutical composition for preventing or treating liver cirrhosis according to claim 3, wherein the fraction is an organic solvent fraction selected from hexane, ether, ethyl acetate and butanol. 제 1 항에 있어서, 상기 추출물은 메탄올 및 에탄올 중에서 선택되는 어느 하나의 저급알코올, 또는 물과 상기 저급알코올의 혼합용매로 추출하여 제조된 것을 특징으로 하는 간경화 예방 또는 치료용 약제학적 조성물.The pharmaceutical composition for preventing or treating liver cirrhosis according to claim 1, wherein the extract is prepared by extracting any one of lower alcohols selected from methanol and ethanol, or a mixed solvent of water and the lower alcohols.
KR1020070047221A 2007-05-15 2007-05-15 Composition prepared from lythrum salicaia having antioxidant and liver protecting activities KR100852737B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
KR1020070047221A KR100852737B1 (en) 2007-05-15 2007-05-15 Composition prepared from lythrum salicaia having antioxidant and liver protecting activities
CN2008101611100A CN101347471B (en) 2007-05-15 2008-05-15 Composition prepared from lythrum salicaia having antioxidant and liver protecting activities

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020070047221A KR100852737B1 (en) 2007-05-15 2007-05-15 Composition prepared from lythrum salicaia having antioxidant and liver protecting activities

Publications (1)

Publication Number Publication Date
KR100852737B1 true KR100852737B1 (en) 2008-08-20

Family

ID=39878135

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020070047221A KR100852737B1 (en) 2007-05-15 2007-05-15 Composition prepared from lythrum salicaia having antioxidant and liver protecting activities

Country Status (2)

Country Link
KR (1) KR100852737B1 (en)
CN (1) CN101347471B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101437634B1 (en) 2012-03-21 2014-09-15 대한민국 Composition for hangover solution using plant extract
WO2016102874A1 (en) 2014-12-23 2016-06-30 Basf Beauty Care Solutions France Sas Use of an extract of lythrum salicaria

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
논문 Gut (1990).*
논문 Pharmaceutical Biology (2003).*

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101437634B1 (en) 2012-03-21 2014-09-15 대한민국 Composition for hangover solution using plant extract
WO2016102874A1 (en) 2014-12-23 2016-06-30 Basf Beauty Care Solutions France Sas Use of an extract of lythrum salicaria
US10285930B2 (en) 2014-12-23 2019-05-14 Basf Beauty Care Solutions France Sas Cosmetic and therapeutic methods utilizing an extract of lythrum salicaria

Also Published As

Publication number Publication date
CN101347471A (en) 2009-01-21
CN101347471B (en) 2012-02-01

Similar Documents

Publication Publication Date Title
Rajha et al. Recent advances in research on polyphenols: effects on microbiota, metabolism, and health
KR101704874B1 (en) Cosmetic Compositions with Whitening and Anti-oxidative Effect Comprising of Phragmitis Rhizoma, Salicomia herbacea L. and Prunus mume
Ahmed et al. Anti-oxidant activity of Pistachia khinjuk supported by phytochemical investigation
TWI466686B (en) Whitening agents, anti-aging agents and antioxidants, and whitening endermic agents, anti-aging and anti-skin external oxidation method for producing a skin external preparation of
Venkatachalam et al. Phytochemical screening in vitro antioxidant activity of Psidium guajava
Povi et al. Phytochemical screening, antioxidant and hypoglycemic activity of Coccoloba uvifera leaves and Waltheria indica roots extracts
Arunachalam et al. Wound healing and antigenotoxic activities of Aegle marmelos with relation to its antioxidant properties
Picerno et al. An extract of Lannea microcarpa: composition, activity and evaluation of cutaneous irritation in cell cultures and reconstituted human epidermis
Rtibi et al. The potential of Thymus vulgaris aqueous extract to protect against delayed gastric emptying and colonic constipation in rats
JP5546040B2 (en) Plum extract and its production method and use
James et al. INVITRO AND INVIVO STUDIES ON THE ANTIOXIDATIVE ACTIVITIES, MEMBRANE STABILIZATION AND CYTOTOXICITY OF WATER SPINACH (Ipomoea aquatica Forsk) FROM IBAJI PONDS, NIGERIA.
KR100852737B1 (en) Composition prepared from lythrum salicaia having antioxidant and liver protecting activities
Sakat et al. Comparative study of Erythrina indica Lam.(Febaceae) leaves extracts for antioxidant activity
Kalaivani et al. Anti-hyperglycemic and antioxidant properties of Cassia auriculata leaves and flowers on alloxan induced diabetic rats
CN114081178B (en) Rosa roxburghii pomace combined phenol with remarkable antioxidant activity and preparation method and application thereof
Chahal et al. In-vivo study of Boswellia serrata for modulating immune system and quenching free radicals
Maryam et al. Effect of ethanolic leaf extract of Senna fistula on some haematological parameters, lipid profile and oxidative stress in alloxan-induced diabetic rats
Nakagawa et al. Activity of Wen-Pi-Tang, and purified constituents of Rhei Rhizoma and glycyrrhizae radix against glucose-mediated protein damage
KR20080028029A (en) Cosmetic compositions comprising paulownia coreana uyeki leaf extract
Khani et al. Investigating the Effect of Hydroalcoholic Extract of Eryngos on Plasma Concentration of Blood Glucose, Blood Cells and Pancreatic Tissue in Diabetic Rats.
Chatterjee et al. Anti diabetic and anti oxidative potencies study of ethyl acetate fraction of hydromethanolic (40: 60) extract of seed of Eugenia jambolana Linn and its chromatographic purification
Jain et al. Antioxidant and free radical scavenging properties of traditionally used three Indian medicinal plants
PANCHANATHAN et al. Evidence of anti-hyperglycemic and anti-oxidant effect of Passiflora edulis flavicarpa (Sims.) in streptozotocin induced diabetic rats
Nzekwe et al. Effect of taraxacum officinale leaf extract on liver antioxidant status in streptozotocin-induced diabetic male wistar rats
KR101828204B1 (en) Anti-atopic composition using the extract of cornus officinalis

Legal Events

Date Code Title Description
A201 Request for examination
A302 Request for accelerated examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant